No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 1uwkB, 0.5712, 3.82, 0.080, 553, 87, THE HIGH RESOLUTION STRUCTURE OF UROCANATE HYDRATASE FROM PSEUDOMONAS PUTIDA IN COMPLEX WITH UROCANATE
2, 1uwlB, 0.5711, 3.82, 0.080, 550, 87, 1.76A STRUCTURE OF UROCANATE HYDRATASE FROM PSEUDOMONAS PUTIDA
3, 1uwlA, 0.5707, 3.81, 0.080, 550, 87, 1.76A STRUCTURE OF UROCANATE HYDRATASE FROM PSEUDOMONAS PUTIDA
4, 1uwkA, 0.5706, 3.81, 0.080, 554, 87, THE HIGH RESOLUTION STRUCTURE OF UROCANATE HYDRATASE FROM PSEUDOMONAS PUTIDA IN COMPLEX WITH UROCANATE
5, 2v7gD, 0.5666, 3.86, 0.080, 553, 87, CRYSTAL STRUCTURE OF AN ENGINEERED UROCANASE TETRAMER
6, 6qb7D, 0.5504, 3.28, 0.532, 112, 79, STRUCTURE OF THE H1 DOMAIN OF HUMAN KCTD16 
7, 6qb7E, 0.5502, 3.27, 0.532, 113, 79, STRUCTURE OF THE H1 DOMAIN OF HUMAN KCTD16 
8, 6qb7A, 0.5484, 3.29, 0.519, 114, 79, STRUCTURE OF THE H1 DOMAIN OF HUMAN KCTD16 
9, 6qb7C, 0.5461, 3.32, 0.519, 112, 79, STRUCTURE OF THE H1 DOMAIN OF HUMAN KCTD16 
10, 6qb7B, 0.5456, 3.32, 0.519, 114, 79, STRUCTURE OF THE H1 DOMAIN OF HUMAN KCTD16 
11, 6qzlC, 0.5416, 2.92, 0.378, 100, 74, STRUCTURE OF THE H1 DOMAIN OF HUMAN KCTD12 
12, 6qzlB, 0.5410, 3.42, 0.551, 98, 78, STRUCTURE OF THE H1 DOMAIN OF HUMAN KCTD12 
13, 6qzlE, 0.5406, 3.25, 0.558, 93, 77, STRUCTURE OF THE H1 DOMAIN OF HUMAN KCTD12 
14, 6qzlA, 0.5364, 3.41, 0.544, 103, 79, STRUCTURE OF THE H1 DOMAIN OF HUMAN KCTD12 
15, 6g57C, 0.5330, 2.89, 0.479, 88, 73, STRUCTURE OF THE H1 DOMAIN OF HUMAN KCTD8 
16, 6qzlD, 0.5320, 3.30, 0.566, 96, 76, STRUCTURE OF THE H1 DOMAIN OF HUMAN KCTD12 
17, 2v7gB, 0.5312, 4.19, 0.045, 553, 89, CRYSTAL STRUCTURE OF AN ENGINEERED UROCANASE TETRAMER
18, 6m8sM, 0.5291, 3.36, 0.545, 106, 77, CRYSTAL STRUCTURE OF THE KCTD12 H1 DOMAIN IN COMPLEX WITH GBETA1GAMMA2 SUBUNITS 
19, 6m8sO, 0.5289, 3.38, 0.558, 105, 77, CRYSTAL STRUCTURE OF THE KCTD12 H1 DOMAIN IN COMPLEX WITH GBETA1GAMMA2 SUBUNITS 
20, 6m8sP, 0.5281, 3.35, 0.558, 104, 77, CRYSTAL STRUCTURE OF THE KCTD12 H1 DOMAIN IN COMPLEX WITH GBETA1GAMMA2 SUBUNITS 
21, 2v7gA, 0.5280, 4.21, 0.045, 553, 89, CRYSTAL STRUCTURE OF AN ENGINEERED UROCANASE TETRAMER
22, 6m8sA, 0.5274, 3.38, 0.558, 104, 77, CRYSTAL STRUCTURE OF THE KCTD12 H1 DOMAIN IN COMPLEX WITH GBETA1GAMMA2 SUBUNITS 
23, 1w1uA, 0.5264, 4.23, 0.056, 550, 90, INACTIVE UROCANASE-SA COCRYSTALLIZED WITH UROCANATE
24, 6m8sB, 0.5258, 3.35, 0.545, 101, 77, CRYSTAL STRUCTURE OF THE KCTD12 H1 DOMAIN IN COMPLEX WITH GBETA1GAMMA2 SUBUNITS 
25, 4xm5A, 0.5251, 4.06, 0.096, 267, 83, C. GLABRATA SLX1.
26, 1w1uB, 0.5242, 4.23, 0.067, 550, 90, INACTIVE UROCANASE-SA COCRYSTALLIZED WITH UROCANATE
27, 2v7gC, 0.5227, 4.35, 0.066, 553, 91, CRYSTAL STRUCTURE OF AN ENGINEERED UROCANASE TETRAMER
28, 5ngkB, 0.5226, 4.05, 0.025, 455, 81, THE ENDO-BETA16-GLUCANASE BT3312
29, 4mzdA, 0.5222, 3.76, 0.073, 356, 82, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE NISIN LEADER PEPTIDASE NISP FROM LACTOCOCCUS LACTIS
30, 6g57B, 0.5221, 3.29, 0.521, 93, 73, STRUCTURE OF THE H1 DOMAIN OF HUMAN KCTD8 
31, 5jy9B, 0.5220, 3.57, 0.111, 424, 81, AN IRON-BOUND STRUCTURE OF THE SALICYLATE SYNTHASE IRP9
32, 3qfhH, 0.5216, 3.87, 0.072, 426, 83, 2.05 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF EPIDERMIN LEADER PEPTIDE PROCESSING SERINE PROTEASE (EPIP) FROM STAPHYLOCOCCUS AUREUS.
33, 5ngkC, 0.5215, 3.93, 0.026, 454, 78, THE ENDO-BETA16-GLUCANASE BT3312
34, 3qfhD, 0.5211, 3.87, 0.072, 426, 83, 2.05 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF EPIDERMIN LEADER PEPTIDE PROCESSING SERINE PROTEASE (EPIP) FROM STAPHYLOCOCCUS AUREUS.
35, 3qfhB, 0.5205, 3.92, 0.072, 425, 83, 2.05 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF EPIDERMIN LEADER PEPTIDE PROCESSING SERINE PROTEASE (EPIP) FROM STAPHYLOCOCCUS AUREUS.
36, 3qfhE, 0.5204, 3.88, 0.072, 426, 83, 2.05 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF EPIDERMIN LEADER PEPTIDE PROCESSING SERINE PROTEASE (EPIP) FROM STAPHYLOCOCCUS AUREUS.
37, 6qm7X, 0.5203, 4.11, 0.074, 204, 81, LEISHMANIA TARENTOLAE PROTEASOME 20S SUBUNIT COMPLEXED WITH GSK3494245 
38, 3jcoJA, 0.5203, 3.21, 0.066, 243, 76, 
39, 3jcoJ, 0.5203, 3.21, 0.066, 243, 76, 
40, 6qm7J, 0.5202, 3.21, 0.066, 243, 76, LEISHMANIA TARENTOLAE PROTEASOME 20S SUBUNIT COMPLEXED WITH GSK3494245 
41, 3qfhF, 0.5201, 4.12, 0.074, 204, 81, 2.05 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF EPIDERMIN LEADER PEPTIDE PROCESSING SERINE PROTEASE (EPIP) FROM STAPHYLOCOCCUS AUREUS.
42, 4gilA, 0.5199, 3.88, 0.072, 426, 83, CRYSTAL STRUCTURE OF PSEUDOURIDINE MONOPHOSPHATE GLYCOSIDASE/LINEAR PSEUDOURIDINE 5 -PHOSPHATE ADDUCT
43, 3t41A, 0.5199, 4.04, 0.081, 307, 86, 1.95 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF EPIDERMIN LEADER PEPTIDE PROCESSING SERINE PROTEASE (EPIP) S393A MUTANT FROM STAPHYLOCOCCUS AUREUS
44, 3qfhA, 0.5199, 3.92, 0.084, 423, 83, 2.05 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF EPIDERMIN LEADER PEPTIDE PROCESSING SERINE PROTEASE (EPIP) FROM STAPHYLOCOCCUS AUREUS.
45, 3qfhC, 0.5197, 3.93, 0.072, 424, 83, 2.05 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF EPIDERMIN LEADER PEPTIDE PROCESSING SERINE PROTEASE (EPIP) FROM STAPHYLOCOCCUS AUREUS.
46, 3qfhG, 0.5196, 3.89, 0.072, 421, 83, 2.05 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF EPIDERMIN LEADER PEPTIDE PROCESSING SERINE PROTEASE (EPIP) FROM STAPHYLOCOCCUS AUREUS.
47, 6r70Z, 0.5193, 3.89, 0.072, 421, 83, ENDOGENEOUS NATIVE HUMAN 20S PROTEASOME 
48, 6fvvA, 0.5185, 3.70, 0.077, 213, 78, struct.pdbx_descriptor              
49, 3jcpJA, 0.5185, 3.35, 0.079, 241, 76, 
50, 3jcpJ, 0.5185, 3.85, 0.053, 222, 76, 
51, 4gimA, 0.5184, 3.27, 0.079, 243, 76, CRYSTAL STRUCTURE OF PSEUDOURIDINE MONOPHOSPHATE GLYCOSIDASE COMPLEXED WITH PSEUDOURIDINE 5 -PHOSPHATE
52, 3t41B, 0.5182, 3.27, 0.079, 243, 76, 1.95 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF EPIDERMIN LEADER PEPTIDE PROCESSING SERINE PROTEASE (EPIP) S393A MUTANT FROM STAPHYLOCOCCUS AUREUS
53, 6r70L, 0.5180, 3.27, 0.079, 243, 76, ENDOGENEOUS NATIVE HUMAN 20S PROTEASOME 
54, 3wxrO, 0.5180, 4.02, 0.106, 306, 85, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
55, 4gimB, 0.5178, 3.87, 0.085, 420, 82, CRYSTAL STRUCTURE OF PSEUDOURIDINE MONOPHOSPHATE GLYCOSIDASE COMPLEXED WITH PSEUDOURIDINE 5 -PHOSPHATE
56, 4tvwA, 0.5177, 3.80, 0.089, 213, 79, RESORUFIN LIGASE WITH BOUND RESORUFIN-AMP ANALOG
57, 4tvwB, 0.5172, 3.31, 0.079, 243, 76, RESORUFIN LIGASE WITH BOUND RESORUFIN-AMP ANALOG
58, 6g57D, 0.5171, 4.06, 0.103, 306, 87, STRUCTURE OF THE H1 DOMAIN OF HUMAN KCTD8 
59, 6fvuM, 0.5170, 3.29, 0.092, 337, 76, struct.pdbx_descriptor              
60, 1rypA, 0.5170, 3.31, 0.092, 337, 76, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
61, 5lf3Z, 0.5169, 3.24, 0.548, 82, 73, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
62, 6ef36, 0.5168, 3.82, 0.053, 222, 76, YEAST 26S PROTEASOME BOUND TO UBIQUITINATED SUBSTRATE (4D MOTOR STATE) 
63, 4cr4A, 0.5168, 3.32, 0.079, 243, 76, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
64, 4gilC, 0.5166, 3.83, 0.089, 213, 79, CRYSTAL STRUCTURE OF PSEUDOURIDINE MONOPHOSPHATE GLYCOSIDASE/LINEAR PSEUDOURIDINE 5 -PHOSPHATE ADDUCT
65, 6fvyA, 0.5165, 3.68, 0.064, 220, 78, struct.pdbx_descriptor              
66, 3une2, 0.5165, 3.36, 0.079, 243, 76, MOUSE CONSTITUTIVE 20S PROTEASOME
67, 3a7aA, 0.5163, 4.07, 0.081, 304, 86, CRYSTAL STRUCTURE OF E. COLI LIPOATE-PROTEIN LIGASE A IN COMPLEX WITH OCTYL-AMP AND APOH-PROTEIN
68, 6epcG, 0.5160, 3.35, 0.079, 244, 76, GROUND STATE 26S PROTEASOME (GS2)
69, 5gjqf, 0.5160, 3.88, 0.078, 222, 77, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
70, 3a7aC, 0.5160, 3.74, 0.090, 213, 78, CRYSTAL STRUCTURE OF E. COLI LIPOATE-PROTEIN LIGASE A IN COMPLEX WITH OCTYL-AMP AND APOH-PROTEIN
71, 4tvwD, 0.5159, 3.36, 0.092, 337, 76, RESORUFIN LIGASE WITH BOUND RESORUFIN-AMP ANALOG
72, 4tvwC, 0.5157, 3.78, 0.090, 245, 78, RESORUFIN LIGASE WITH BOUND RESORUFIN-AMP ANALOG
73, 4cr2A, 0.5155, 3.83, 0.089, 213, 79, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
74, 4ltcU, 0.5152, 3.37, 0.092, 337, 76, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
75, 4ltcG, 0.5152, 3.32, 0.092, 337, 76, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
76, 4x6zO, 0.5151, 3.33, 0.092, 337, 76, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
77, 4q1sU, 0.5151, 3.38, 0.079, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
78, 4gikB, 0.5150, 3.34, 0.079, 243, 76, CRYSTAL STRUCTURE OF PSEUDOURIDINE MONOPHOSPHATE GLYCOSIDASE/LINEAR R5P ADDUCT
79, 3hyeG, 0.5148, 3.34, 0.079, 243, 76, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
80, 2zcyU, 0.5148, 3.33, 0.079, 241, 76, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
81, 4r3oM, 0.5147, 3.35, 0.079, 243, 76, HUMAN CONSTITUTIVE 20S PROTEASOME
82, 2zcyG, 0.5146, 4.07, 0.105, 307, 86, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
83, 4r02U, 0.5145, 3.33, 0.079, 243, 76, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
84, 3e47G, 0.5145, 3.34, 0.079, 243, 76, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
85, 6g57A, 0.5144, 3.72, 0.090, 213, 78, STRUCTURE OF THE H1 DOMAIN OF HUMAN KCTD8 
86, 3e47U, 0.5144, 3.34, 0.079, 243, 76, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
87, 5t0cKB, 0.5142, 3.35, 0.079, 241, 76, 
88, 5t0cEA, 0.5142, 3.34, 0.079, 243, 76, 
89, 4r17U, 0.5142, 3.70, 0.697, 97, 76, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
90, 3oeuG, 0.5142, 3.34, 0.079, 243, 76, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
91, 3d29U, 0.5142, 3.73, 0.090, 213, 78, PROTEASOME INHIBITION BY FELLUTAMIDE B
92, 6fvvM, 0.5141, 3.73, 0.090, 213, 78, struct.pdbx_descriptor              
93, 4u39I, 0.5141, 3.34, 0.079, 241, 76, CRYSTAL STRUCTURE OF FTSZ:MCIZ COMPLEX FROM BACILLUS SUBTILIS
94, 4r17G, 0.5141, 3.36, 0.079, 243, 76, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
95, 4nnwU, 0.5141, 3.34, 0.079, 243, 76, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
96, 4nnwG, 0.5141, 4.02, 0.063, 222, 79, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
97, 3mg6G, 0.5141, 3.94, 0.060, 270, 84, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
98, 6hwfU, 0.5140, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH ONX 0914 
99, 3un8U, 0.5140, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
100, 3d29G, 0.5140, 3.35, 0.079, 241, 76, PROTEASOME INHIBITION BY FELLUTAMIDE B
101, 6mseUA, 0.5139, 3.35, 0.079, 243, 76, struct.pdbx_descriptor               26S proteasome  
102, 6mseGA, 0.5139, 3.35, 0.079, 241, 76, struct.pdbx_descriptor               26S proteasome  
103, 6hucU, 0.5139, 3.34, 0.079, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 18 
104, 6hucG, 0.5139, 3.34, 0.079, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 18 
105, 5vfqM, 0.5139, 3.68, 0.078, 213, 77, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
106, 4y8rU, 0.5139, 3.68, 0.078, 213, 77, YEAST 20S PROTEASOME BETA2-H116D MUTANT
107, 4y8rG, 0.5139, 3.33, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-H116D MUTANT
108, 3shjG, 0.5139, 3.33, 0.079, 241, 76, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
109, 6hwfG, 0.5138, 3.78, 0.090, 213, 78, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH ONX 0914 
110, 6hv4U, 0.5138, 4.34, 0.122, 215, 82, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH ONX 0914 
111, 6hv4G, 0.5138, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH ONX 0914 
112, 6huqU, 0.5138, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 20 
113, 4j70U, 0.5138, 3.34, 0.079, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
114, 6huqG, 0.5137, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 20 
115, 5l5uU, 0.5137, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
116, 5l5uG, 0.5137, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
117, 4ya4U, 0.5137, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-H114D MUTANT
118, 4ya4G, 0.5137, 3.36, 0.079, 243, 76, YEAST 20S PROTEASOME BETA2-H114D MUTANT
119, 4j70G, 0.5137, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
120, 3un8G, 0.5137, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
121, 3shjU, 0.5137, 3.34, 0.079, 241, 76, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
122, 3sdkU, 0.5137, 3.34, 0.079, 241, 76, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
123, 3gpwG, 0.5137, 3.34, 0.079, 241, 76, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
124, 3dy4L, 0.5137, 3.35, 0.079, 243, 76, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
125, 3a7rA, 0.5137, 3.35, 0.079, 243, 76, CRYSTAL STRUCTURE OF E. COLI LIPOATE-PROTEIN LIGASE A IN COMPLEX WITH LIPOYL-AMP.
126, 6qm8X, 0.5136, 3.34, 0.079, 243, 76, LEISHMANIA TARENTOLAE PROTEASOME 20S SUBUNIT APO STRUCTURE 
127, 4x6zA, 0.5136, 3.35, 0.079, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
128, 4qlsG, 0.5136, 3.34, 0.079, 243, 76, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
129, 3nzjU, 0.5136, 3.66, 0.067, 222, 75, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
130, 3nzjG, 0.5136, 3.39, 0.092, 337, 76, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
131, 3dy4U, 0.5136, 3.75, 0.065, 204, 77, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
132, 2w3yA, 0.5136, 3.34, 0.079, 242, 76, STRUCTURE OF THE EVF VIRULENCE FACTOR
133, 6hvuU, 0.5135, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 29 
134, 6hvsU, 0.5135, 3.34, 0.079, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 18 
135, 6hvsG, 0.5135, 3.34, 0.079, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 18 
136, 6huuU, 0.5135, 3.34, 0.079, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 29 
137, 6gopU, 0.5135, 3.18, 0.067, 267, 75, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
138, 5d0wU, 0.5135, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-T1S MUTANT
139, 5d0wG, 0.5135, 3.33, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-T1S MUTANT
140, 5bxlU, 0.5135, 3.33, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-G170A MUTANT
141, 5bxlG, 0.5135, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-G170A MUTANT
142, 4y8tG, 0.5135, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
143, 4jsuU, 0.5135, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
144, 4jsuG, 0.5135, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
145, 3dy4Z, 0.5135, 3.34, 0.079, 241, 76, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
146, 6hvuG, 0.5134, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 29 
147, 5nifA, 0.5134, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
148, 4qv9U, 0.5134, 3.34, 0.079, 243, 76, YCP BETA5-C63F MUTANT
149, 4qv9G, 0.5134, 3.34, 0.079, 243, 76, YCP BETA5-C63F MUTANT
150, 4quyU, 0.5134, 3.66, 0.067, 222, 75, YCP BETA5-A49S-MUTANT
151, 4qlsU, 0.5134, 3.35, 0.079, 241, 76, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
152, 6hw3U, 0.5133, 3.33, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 13 
153, 6hw3G, 0.5133, 3.33, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 13 
154, 6hvwU, 0.5133, 3.33, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 43 
155, 6huuG, 0.5133, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 29 
156, 6htpU, 0.5133, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 7 
157, 6gopG, 0.5133, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
158, 6epeG, 0.5133, 3.35, 0.079, 241, 76, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
159, 5czaU, 0.5133, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-D166N MUTANT
160, 5cghU, 0.5133, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
161, 4zzgA, 0.5133, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
162, 4y8tU, 0.5133, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
163, 4qwuU, 0.5133, 3.91, 0.065, 245, 77, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
164, 4qwuG, 0.5133, 3.34, 0.079, 241, 76, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
165, 4qv6U, 0.5133, 3.35, 0.079, 241, 76, YCP BETA5-A49V MUTANT
166, 4qv6G, 0.5133, 3.34, 0.079, 241, 76, YCP BETA5-A49V MUTANT
167, 4quyG, 0.5133, 3.36, 0.079, 241, 76, YCP BETA5-A49S-MUTANT
168, 4gk7U, 0.5133, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
169, 3dy4G, 0.5133, 3.35, 0.079, 241, 76, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
170, 6qm7O, 0.5132, 3.34, 0.079, 241, 76, LEISHMANIA TARENTOLAE PROTEASOME 20S SUBUNIT COMPLEXED WITH GSK3494245 
171, 6hvwG, 0.5132, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 43 
172, 6htdU, 0.5132, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 4 
173, 5l69U, 0.5132, 3.34, 0.079, 243, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
174, 5l69G, 0.5132, 3.35, 0.079, 243, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
175, 5l5rG, 0.5132, 3.60, 0.091, 244, 77, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
176, 5fgaU, 0.5132, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
177, 5fgaG, 0.5132, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
178, 5czaG, 0.5132, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-D166N MUTANT
179, 5cghG, 0.5132, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
180, 4qz4U, 0.5132, 3.34, 0.079, 241, 76, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
181, 4qz4G, 0.5132, 3.35, 0.079, 241, 76, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
182, 4qltU, 0.5132, 3.35, 0.079, 241, 76, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
183, 4gk7G, 0.5132, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
184, 3sdiU, 0.5132, 3.35, 0.079, 241, 76, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
185, 6htpG, 0.5131, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 7 
186, 5l5rU, 0.5131, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
187, 5l5bU, 0.5131, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
188, 5l5bG, 0.5131, 3.34, 0.079, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
189, 5fggU, 0.5131, 3.35, 0.079, 240, 76, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
190, 5cgfU, 0.5131, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-G48C MUTANT
191, 5cgfG, 0.5131, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-G48C MUTANT
192, 4ya9U, 0.5131, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
193, 4y9yU, 0.5131, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-H116E MUTANT
194, 4y9yG, 0.5131, 3.33, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-H116E MUTANT
195, 4qwlU, 0.5131, 3.35, 0.079, 241, 76, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
196, 4qltG, 0.5131, 3.35, 0.079, 241, 76, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
197, 4nnnU, 0.5131, 3.35, 0.079, 241, 76, YCP IN COMPLEX WITH MG132
198, 4hrdU, 0.5131, 3.35, 0.079, 241, 76, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
199, 3sdiG, 0.5131, 3.35, 0.079, 241, 76, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
200, 3oevU, 0.5131, 3.34, 0.079, 241, 76, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
201, 3gpjU, 0.5131, 3.35, 0.079, 241, 76, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
202, 3bdmU, 0.5131, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
203, 3bdmG, 0.5131, 3.36, 0.079, 243, 76, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
204, 6qm7A, 0.5130, 3.36, 0.079, 240, 76, LEISHMANIA TARENTOLAE PROTEASOME 20S SUBUNIT COMPLEXED WITH GSK3494245 
205, 6hvvU, 0.5130, 3.35, 0.079, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 39 
206, 6hv5U, 0.5130, 3.34, 0.079, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 4 
207, 6huvU, 0.5130, 3.35, 0.079, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 39 
208, 6huvG, 0.5130, 3.35, 0.079, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 39 
209, 6hubU, 0.5130, 3.60, 0.091, 244, 77, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 16 
210, 6htdG, 0.5130, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 4 
211, 5l6aU, 0.5130, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
212, 5l55U, 0.5130, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
213, 5fggG, 0.5130, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
214, 4ya9G, 0.5130, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
215, 4y9zU, 0.5130, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
216, 4y9zG, 0.5130, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
217, 4u39H, 0.5130, 3.34, 0.079, 241, 76, CRYSTAL STRUCTURE OF FTSZ:MCIZ COMPLEX FROM BACILLUS SUBTILIS
218, 4qwlG, 0.5130, 3.33, 0.079, 241, 76, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
219, 4no6U, 0.5130, 3.35, 0.079, 241, 76, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
220, 4nnnG, 0.5130, 3.35, 0.079, 241, 76, YCP IN COMPLEX WITH MG132
221, 3tddU, 0.5130, 3.35, 0.079, 241, 76, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
222, 3gpjG, 0.5130, 4.00, 0.071, 269, 85, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
223, 6hvrU, 0.5129, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 16 
224, 6hv5G, 0.5129, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 4 
225, 6hubG, 0.5129, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 16 
226, 5laiU, 0.5129, 3.34, 0.079, 243, 76, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
227, 5laiG, 0.5129, 3.34, 0.079, 243, 76, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
228, 5l6aG, 0.5129, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
229, 5l5sU, 0.5129, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
230, 5l5sG, 0.5129, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
231, 5l5aU, 0.5129, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
232, 5l5aG, 0.5129, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
233, 5l55G, 0.5129, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
234, 4ya7U, 0.5129, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
235, 4ya7G, 0.5129, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
236, 4qv1U, 0.5129, 3.35, 0.079, 241, 76, YCP BETA5-M45A MUTANT
237, 4qv1G, 0.5129, 3.35, 0.079, 241, 76, YCP BETA5-M45A MUTANT
238, 4no6G, 0.5129, 3.34, 0.079, 241, 76, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
239, 3mg0G, 0.5129, 3.35, 0.079, 241, 76, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
240, 3dy3U, 0.5129, 3.35, 0.079, 241, 76, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
241, 3dy3G, 0.5129, 3.35, 0.079, 241, 76, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
242, 6hvvG, 0.5128, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 39 
243, 6hvrG, 0.5128, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 16 
244, 6htbU, 0.5128, 3.36, 0.079, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) 
245, 5l5hU, 0.5128, 3.35, 0.079, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
246, 5l5hG, 0.5128, 3.35, 0.079, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
247, 5fg7U, 0.5128, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-T1A MUTANT
248, 5fg7G, 0.5128, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-T1A MUTANT
249, 4r18U, 0.5128, 3.36, 0.079, 241, 76, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
250, 4r18G, 0.5128, 3.35, 0.079, 241, 76, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
251, 3mg8U, 0.5128, 3.35, 0.079, 241, 76, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
252, 6hvtU, 0.5127, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 20 
253, 6hvtG, 0.5127, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 20 
254, 6hvaU, 0.5127, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 13 
255, 5bxnU, 0.5127, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
256, 5bxnG, 0.5127, 3.35, 0.079, 243, 76, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
257, 4qz6U, 0.5127, 3.35, 0.079, 241, 76, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
258, 3mg6U, 0.5127, 3.36, 0.079, 241, 76, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
259, 6hwdU, 0.5126, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH BORTEZOMIB 
260, 6hvaG, 0.5126, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 13 
261, 6htbG, 0.5126, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) 
262, 5l54U, 0.5126, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
263, 5l52U, 0.5126, 3.35, 0.079, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
264, 5jhrU, 0.5126, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
265, 5jhrG, 0.5126, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
266, 5d0vU, 0.5126, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
267, 5d0vG, 0.5126, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
268, 5cggU, 0.5126, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
269, 5cggG, 0.5126, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
270, 4y8sU, 0.5126, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
271, 4qz6G, 0.5126, 3.35, 0.079, 241, 76, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
272, 4qz0U, 0.5126, 3.35, 0.079, 241, 76, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
273, 4qvlU, 0.5126, 3.34, 0.079, 241, 76, YCP IN COMPLEX WITH BORTEZOMIB
274, 4qv7U, 0.5126, 3.34, 0.079, 241, 76, YCP BETA5-A50V MUTANT
275, 4inrG, 0.5126, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
276, 3mg8G, 0.5126, 3.35, 0.079, 241, 76, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
277, 3mg0U, 0.5126, 3.35, 0.079, 241, 76, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
278, 6hwdG, 0.5125, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH BORTEZOMIB 
279, 6hwbU, 0.5125, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 44B 
280, 6hw4U, 0.5125, 3.36, 0.079, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 16 
281, 6hw4G, 0.5125, 3.37, 0.079, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 16 
282, 5l54G, 0.5125, 3.35, 0.079, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
283, 5l52G, 0.5125, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
284, 5cz8U, 0.5125, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
285, 4ya1U, 0.5125, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-H116N MUTANT
286, 4ya1G, 0.5125, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-H116N MUTANT
287, 4y8sG, 0.5125, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
288, 4y8pU, 0.5125, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
289, 4y75U, 0.5125, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
290, 4y75G, 0.5125, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
291, 4qz0G, 0.5125, 3.35, 0.079, 241, 76, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
292, 4qw1U, 0.5125, 3.35, 0.079, 241, 76, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
293, 4qw1G, 0.5125, 3.35, 0.079, 241, 76, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
294, 4qvnU, 0.5125, 3.35, 0.079, 241, 76, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
295, 4qvnG, 0.5125, 3.35, 0.079, 241, 76, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
296, 4qvlG, 0.5125, 3.35, 0.079, 241, 76, YCP IN COMPLEX WITH BORTEZOMIB
297, 4qv7G, 0.5125, 3.36, 0.079, 241, 76, YCP BETA5-A50V MUTANT
298, 4qv0G, 0.5125, 3.36, 0.079, 241, 76, YCP BETA5-A49T-A50V-DOUBLE MUTANT
299, 4qlvU, 0.5125, 3.35, 0.079, 241, 76, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
300, 4qlvG, 0.5125, 3.35, 0.079, 241, 76, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
301, 3mg4G, 0.5125, 3.35, 0.079, 241, 76, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
302, 6qm8A, 0.5124, 3.35, 0.079, 241, 76, LEISHMANIA TARENTOLAE PROTEASOME 20S SUBUNIT APO STRUCTURE 
303, 6hv7G, 0.5124, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 7 
304, 5l65U, 0.5124, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
305, 5l65G, 0.5124, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
306, 5l63U, 0.5124, 3.36, 0.079, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
307, 5l63G, 0.5124, 3.61, 0.091, 244, 77, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
308, 5l5pU, 0.5124, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
309, 5cz8G, 0.5124, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
310, 4y8pG, 0.5124, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
311, 4y8iU, 0.5124, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
312, 4y8iG, 0.5124, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
313, 4qz5U, 0.5124, 3.36, 0.079, 241, 76, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
314, 4qz5G, 0.5124, 3.35, 0.079, 241, 76, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
315, 4qvyU, 0.5124, 3.35, 0.079, 241, 76, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
316, 4qvyG, 0.5124, 3.37, 0.079, 241, 76, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
317, 4qv0U, 0.5124, 3.37, 0.079, 241, 76, YCP BETA5-A49T-A50V-DOUBLE MUTANT
318, 4no8U, 0.5124, 3.35, 0.079, 241, 76, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
319, 6hwcU, 0.5123, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-G45A MUTANT 
320, 6hwbG, 0.5123, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 44B 
321, 6g7fG, 0.5123, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH CYSTARGOLIDE B 
322, 5lttU, 0.5123, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
323, 5l5pG, 0.5123, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
324, 5d0sU, 0.5123, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
325, 5bouU, 0.5123, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
326, 5bouG, 0.5123, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
327, 4y8jU, 0.5123, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
328, 4y8jG, 0.5123, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
329, 4qv8U, 0.5123, 3.35, 0.079, 241, 76, YCP BETA5-C52F MUTANT
330, 4qv8G, 0.5123, 3.37, 0.079, 241, 76, YCP BETA5-C52F MUTANT
331, 4qv5U, 0.5123, 3.37, 0.079, 241, 76, YCP BETA5-M45I MUTANT
332, 4qv5G, 0.5123, 3.36, 0.079, 241, 76, YCP BETA5-M45I MUTANT
333, 4no8G, 0.5123, 3.36, 0.079, 241, 76, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
334, 4inrU, 0.5123, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
335, 4hnpU, 0.5123, 3.35, 0.079, 241, 76, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
336, 6qm8J, 0.5122, 3.35, 0.079, 241, 76, LEISHMANIA TARENTOLAE PROTEASOME 20S SUBUNIT APO STRUCTURE 
337, 6j30F, 0.5122, 3.35, 0.079, 241, 76, struct.pdbx_descriptor              
338, 6hwcG, 0.5122, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-G45A MUTANT 
339, 6hw7U, 0.5122, 3.36, 0.079, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 29 
340, 6hw7G, 0.5122, 3.37, 0.079, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 29 
341, 6hv7U, 0.5122, 3.66, 0.066, 204, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 7 
342, 6g7fU, 0.5122, 3.77, 0.053, 222, 76, YEAST 20S PROTEASOME IN COMPLEX WITH CYSTARGOLIDE B 
343, 5lttG, 0.5122, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
344, 5lajU, 0.5122, 3.36, 0.079, 241, 76, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
345, 5lajG, 0.5122, 3.36, 0.079, 241, 76, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
346, 5l67U, 0.5122, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
347, 5l67G, 0.5122, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
348, 5l5wU, 0.5122, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
349, 5l5wG, 0.5122, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
350, 5l5iU, 0.5122, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
351, 5l5iG, 0.5122, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
352, 5l5dU, 0.5122, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
353, 5l5dG, 0.5122, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
354, 5fg9U, 0.5122, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
355, 5fg9G, 0.5122, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
356, 5d0sG, 0.5122, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
357, 5cz6U, 0.5122, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
358, 5cz6G, 0.5122, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
359, 5ahjU, 0.5122, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
360, 5ahjG, 0.5122, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
361, 4ya2U, 0.5122, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
362, 4y84U, 0.5122, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
363, 4y77U, 0.5122, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
364, 4y77G, 0.5122, 3.34, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
365, 4qz7U, 0.5122, 3.34, 0.079, 241, 76, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
366, 4qz2U, 0.5122, 3.35, 0.079, 241, 76, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
367, 4qwfU, 0.5122, 3.36, 0.079, 241, 76, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
368, 4qwfG, 0.5122, 3.36, 0.079, 241, 76, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
369, 4qw7U, 0.5122, 3.36, 0.079, 241, 76, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
370, 4qw6U, 0.5122, 3.36, 0.079, 241, 76, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
371, 4qw6G, 0.5122, 3.36, 0.079, 241, 76, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
372, 4qvwU, 0.5122, 3.36, 0.079, 241, 76, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
373, 4qlqU, 0.5122, 3.36, 0.079, 241, 76, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
374, 4no1U, 0.5122, 3.35, 0.079, 241, 76, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
375, 4intG, 0.5122, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
376, 4hrcU, 0.5122, 3.35, 0.079, 241, 76, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
377, 5l6cU, 0.5121, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
378, 5l6cG, 0.5121, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
379, 5l6bU, 0.5121, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
380, 5l6bG, 0.5121, 3.36, 0.079, 243, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
381, 5l5zU, 0.5121, 3.37, 0.079, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
382, 4z1lU, 0.5121, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
383, 4ya2G, 0.5121, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
384, 4y8lU, 0.5121, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
385, 4y8hU, 0.5121, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
386, 4y6vU, 0.5121, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
387, 4rurU, 0.5121, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
388, 4rurG, 0.5121, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
389, 4qz7G, 0.5121, 3.36, 0.079, 241, 76, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
390, 4qz3U, 0.5121, 3.35, 0.079, 241, 76, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
391, 4qz2G, 0.5121, 3.37, 0.079, 241, 76, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
392, 4qw5U, 0.5121, 3.37, 0.079, 241, 76, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
393, 4qvwG, 0.5121, 3.37, 0.079, 241, 76, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
394, 4qvpU, 0.5121, 3.36, 0.079, 241, 76, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
395, 4qv4U, 0.5121, 3.36, 0.079, 241, 76, YCP BETA5-M45T MUTANT
396, 4qv4G, 0.5121, 3.36, 0.079, 241, 76, YCP BETA5-M45T MUTANT
397, 4qlqG, 0.5121, 3.35, 0.079, 241, 76, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
398, 4no1G, 0.5121, 3.36, 0.079, 241, 76, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
399, 4jsqG, 0.5121, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
400, 6hw0U, 0.5120, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 7 
401, 6hw0G, 0.5120, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 7 
402, 6htrU, 0.5120, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 13 
403, 5l68U, 0.5120, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
404, 5l68G, 0.5120, 3.36, 0.079, 243, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
405, 5l60U, 0.5120, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
406, 5l60G, 0.5120, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
407, 5l5zG, 0.5120, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
408, 4z1lG, 0.5120, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
409, 4y8mU, 0.5120, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
410, 4y8mG, 0.5120, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
411, 4y8lG, 0.5120, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
412, 4y8hG, 0.5120, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
413, 4y8gU, 0.5120, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
414, 4y8gG, 0.5120, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
415, 4y74U, 0.5120, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
416, 4y70U, 0.5120, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
417, 4y70G, 0.5120, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
418, 4y6vG, 0.5120, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
419, 4qz3G, 0.5120, 3.36, 0.079, 241, 76, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
420, 4qw7G, 0.5120, 3.37, 0.079, 241, 76, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
421, 4qw5G, 0.5120, 3.37, 0.079, 241, 76, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
422, 4qvpG, 0.5120, 3.37, 0.079, 241, 76, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
423, 4quxG, 0.5120, 3.37, 0.079, 241, 76, YCP BETA5-A49T-MUTANT
424, 4q1sG, 0.5120, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
425, 4jsqU, 0.5120, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
426, 3gpjL, 0.5120, 3.35, 0.079, 241, 76, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
427, 1g0uU, 0.5120, 3.36, 0.079, 241, 76, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
428, 6fvyAA, 0.5119, 3.36, 0.079, 241, 76, struct.pdbx_descriptor              
429, 5m2bU, 0.5119, 3.36, 0.079, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
430, 5m2bG, 0.5119, 3.36, 0.079, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
431, 5l62U, 0.5119, 3.60, 0.095, 222, 74, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
432, 5l62G, 0.5119, 3.36, 0.079, 240, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
433, 5l61U, 0.5119, 3.88, 0.078, 222, 77, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
434, 5l61G, 0.5119, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
435, 5l5qU, 0.5119, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
436, 5l5qG, 0.5119, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
437, 5l5eU, 0.5119, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
438, 5l5eG, 0.5119, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
439, 5fgfU, 0.5119, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
440, 5fgfG, 0.5119, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
441, 4y8oU, 0.5119, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
442, 4y8oG, 0.5119, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
443, 4y8kU, 0.5119, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
444, 4y84G, 0.5119, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
445, 4y7yU, 0.5119, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
446, 4y74G, 0.5119, 3.38, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
447, 4r02G, 0.5119, 3.38, 0.079, 241, 76, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
448, 4qwxU, 0.5119, 3.36, 0.079, 241, 76, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
449, 4qw4U, 0.5119, 3.36, 0.079, 241, 76, YCP IN COMPLEX WITH CARFILZOMIB
450, 4qw4G, 0.5119, 3.37, 0.079, 241, 76, YCP IN COMPLEX WITH CARFILZOMIB
451, 4quxU, 0.5119, 3.37, 0.079, 241, 76, YCP BETA5-A49T-MUTANT
452, 2w3yB, 0.5119, 3.36, 0.079, 241, 76, STRUCTURE OF THE EVF VIRULENCE FACTOR
453, 6hvxU, 0.5118, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 4 
454, 6hvxG, 0.5118, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 4 
455, 6hv3U, 0.5118, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) 
456, 6hv3G, 0.5118, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) 
457, 5l64U, 0.5118, 3.24, 0.066, 261, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
458, 5l64G, 0.5118, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
459, 5l5yU, 0.5118, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
460, 5l5yG, 0.5118, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
461, 5l5xU, 0.5118, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
462, 5l5xG, 0.5118, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
463, 5l5fU, 0.5118, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
464, 5l5fG, 0.5118, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
465, 5jhsU, 0.5118, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
466, 5dkiG, 0.5118, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
467, 4y7yG, 0.5118, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
468, 4y7wU, 0.5118, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
469, 4qz1U, 0.5118, 3.36, 0.079, 241, 76, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
470, 4qwxG, 0.5118, 3.36, 0.079, 241, 76, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
471, 4qwrU, 0.5118, 3.39, 0.079, 241, 76, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
472, 4qv3U, 0.5118, 3.37, 0.079, 241, 76, YCP BETA5-M45V MUTANT
473, 4qv3G, 0.5118, 3.37, 0.079, 241, 76, YCP BETA5-M45V MUTANT
474, 4intU, 0.5118, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
475, 3oevG, 0.5118, 3.36, 0.079, 241, 76, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
476, 3gpjZ, 0.5118, 3.36, 0.079, 241, 76, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
477, 6hweU, 0.5117, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH CARFILZOMIB 
478, 6hw8U, 0.5117, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 39 
479, 6hw8G, 0.5117, 3.36, 0.079, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 39 
480, 6htrG, 0.5117, 3.37, 0.079, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 13 
481, 6g8mU, 0.5117, 3.61, 0.095, 222, 74, YEAST 20S PROTEASOME IN COMPLEX WITH CYSTARGOLIDE B DERIVATIVE 1 
482, 6g8mG, 0.5117, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH CYSTARGOLIDE B DERIVATIVE 1 
483, 5l5tU, 0.5117, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
484, 5l5tG, 0.5117, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
485, 5l5jU, 0.5117, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
486, 5l5jG, 0.5117, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
487, 5jhsG, 0.5117, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
488, 5dkjU, 0.5117, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
489, 5dkiU, 0.5117, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
490, 5cgiU, 0.5117, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
491, 5cgiG, 0.5117, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
492, 4y8kG, 0.5117, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
493, 4y7wG, 0.5117, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
494, 4qzzU, 0.5117, 3.39, 0.079, 241, 76, YCP IN COMPLEX WITH OMURALIDE
495, 4qzwU, 0.5117, 3.36, 0.079, 241, 76, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
496, 4qz1G, 0.5117, 3.36, 0.079, 241, 76, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
497, 4qwrG, 0.5117, 3.36, 0.079, 241, 76, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
498, 4qluU, 0.5117, 3.37, 0.079, 241, 76, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
499, 4g4sA, 0.5117, 3.36, 0.079, 241, 76, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
500, 4eu2A, 0.5117, 3.36, 0.079, 241, 76, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
501, 3un4U, 0.5117, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
502, 3un4G, 0.5117, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
503, 6hvyU, 0.5116, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 5 (7- AND 6-MEMBERED RING) 
504, 6htcU, 0.5116, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH ONX 0914 
505, 6fvxM, 0.5116, 3.34, 0.079, 241, 76, struct.pdbx_descriptor              
506, 5dkjG, 0.5116, 3.35, 0.079, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
507, 5d0zU, 0.5116, 3.35, 0.079, 243, 76, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
508, 5d0tU, 0.5116, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
509, 5d0tG, 0.5116, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
510, 4y8nU, 0.5116, 3.75, 0.039, 222, 76, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
511, 4qzzG, 0.5116, 3.37, 0.079, 241, 76, YCP IN COMPLEX WITH OMURALIDE
512, 4qzwG, 0.5116, 3.35, 0.079, 241, 76, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
513, 4qvmU, 0.5116, 3.37, 0.079, 241, 76, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
514, 4qvmG, 0.5116, 3.37, 0.079, 241, 76, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
515, 4qluG, 0.5116, 3.37, 0.079, 241, 76, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
516, 3mg4U, 0.5116, 3.36, 0.079, 241, 76, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
517, 6qm8O, 0.5115, 3.36, 0.079, 241, 76, LEISHMANIA TARENTOLAE PROTEASOME 20S SUBUNIT APO STRUCTURE 
518, 6j2cG, 0.5115, 3.38, 0.079, 241, 76, struct.pdbx_descriptor              
519, 6hweG, 0.5115, 3.38, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH CARFILZOMIB 
520, 6hwaU, 0.5115, 3.35, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 43 
521, 6hw9U, 0.5115, 3.36, 0.079, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 41B 
522, 5l66U, 0.5115, 3.49, 0.092, 244, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
523, 5d0zG, 0.5115, 4.08, 0.127, 229, 79, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
524, 5cz7U, 0.5115, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
525, 4y8nG, 0.5115, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
526, 4y80U, 0.5115, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
527, 4y80G, 0.5115, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
528, 4qxjU, 0.5115, 3.35, 0.079, 241, 76, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
529, 4qxjG, 0.5115, 3.37, 0.079, 241, 76, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
530, 4qvqU, 0.5115, 3.37, 0.079, 241, 76, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
531, 4qvqG, 0.5115, 3.37, 0.079, 241, 76, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
532, 4hrdG, 0.5115, 3.37, 0.079, 241, 76, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
533, 6hwaG, 0.5114, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 43 
534, 6hw9G, 0.5114, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 41B 
535, 6hw6U, 0.5114, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 20 
536, 6hw6G, 0.5114, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 20 
537, 6hvyG, 0.5114, 3.37, 0.079, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 5 (7- AND 6-MEMBERED RING) 
538, 6htcG, 0.5114, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH ONX 0914 
539, 6h39U, 0.5114, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC NON-COVALENT BINDING INHIBITOR RTS-V5 
540, 5l66G, 0.5114, 3.38, 0.079, 241, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
541, 5l5vU, 0.5114, 3.38, 0.079, 241, 76,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
542, 5l5vG, 0.5114, 3.37, 0.079, 241, 76,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
543, 5l5oU, 0.5114, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
544, 5l5oG, 0.5114, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
545, 5cz7G, 0.5114, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
546, 4y81G, 0.5114, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
547, 4qwiU, 0.5114, 3.37, 0.079, 241, 76, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
548, 4qwiG, 0.5114, 3.37, 0.079, 241, 76, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
549, 5d0xU, 0.5113, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
550, 5d0xG, 0.5113, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
551, 5cz9U, 0.5113, 3.38, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
552, 5cz9G, 0.5113, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
553, 5cz4U, 0.5113, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
554, 4ya5U, 0.5113, 3.38, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
555, 4ya0U, 0.5113, 3.38, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
556, 4ya0G, 0.5113, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
557, 4y81U, 0.5113, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
558, 4y69U, 0.5113, 3.38, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
559, 4no9U, 0.5113, 3.38, 0.079, 241, 76, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
560, 4no9G, 0.5113, 3.39, 0.079, 241, 76, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
561, 4inuG, 0.5113, 3.39, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
562, 6h39G, 0.5112, 3.38, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC NON-COVALENT BINDING INHIBITOR RTS-V5 
563, 5vfqLA, 0.5112, 3.38, 0.079, 241, 76, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
564, 5cz4G, 0.5112, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
565, 4ya5G, 0.5112, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
566, 4y8qU, 0.5112, 3.37, 0.079, 243, 76, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
567, 4y7xU, 0.5112, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
568, 4y69G, 0.5112, 3.77, 0.090, 213, 78, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
569, 4r00U, 0.5112, 3.38, 0.079, 241, 76, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
570, 4r00G, 0.5112, 3.38, 0.079, 241, 76, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
571, 1g65G, 0.5112, 3.37, 0.079, 241, 76, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
572, 5fhsU, 0.5111, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
573, 4y8qG, 0.5111, 3.38, 0.079, 241, 76, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
574, 4y82U, 0.5111, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
575, 4y82G, 0.5111, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
576, 4y7xG, 0.5111, 3.37, 0.079, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
577, 6hv4Z, 0.5110, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH ONX 0914 
578, 5fhsG, 0.5110, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
579, 5fghG, 0.5110, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
580, 4y78U, 0.5110, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
581, 4qzxU, 0.5110, 3.38, 0.079, 241, 76, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
582, 4qzxG, 0.5110, 3.68, 0.080, 222, 75, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
583, 1g65T, 0.5110, 3.37, 0.079, 241, 76, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
584, 5fgiU, 0.5109, 3.38, 0.079, 241, 76, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
585, 5fgiG, 0.5109, 3.38, 0.079, 241, 76, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
586, 5fghU, 0.5109, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
587, 4y78G, 0.5109, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
588, 4u39B, 0.5109, 3.98, 0.025, 244, 79, CRYSTAL STRUCTURE OF FTSZ:MCIZ COMPLEX FROM BACILLUS SUBTILIS
589, 4qwkU, 0.5109, 3.37, 0.079, 241, 76, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
590, 4qw0U, 0.5109, 3.37, 0.079, 241, 76, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
591, 4qvvU, 0.5109, 3.38, 0.079, 241, 76, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
592, 5t0gS, 0.5108, 3.38, 0.079, 241, 76, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
593, 5fgeU, 0.5108, 3.98, 0.071, 289, 84, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
594, 5fgeG, 0.5108, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
595, 4qwkG, 0.5108, 3.38, 0.079, 241, 76, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
596, 4qwjU, 0.5108, 3.38, 0.079, 241, 76, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
597, 4qwjG, 0.5108, 3.71, 0.078, 213, 77, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
598, 4qw0G, 0.5108, 3.37, 0.079, 241, 76, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
599, 4qvvG, 0.5108, 3.37, 0.079, 241, 76, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
600, 4inuU, 0.5108, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
601, 5fgdU, 0.5107, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
602, 5fgdG, 0.5107, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
603, 4y8uU, 0.5107, 3.38, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
604, 4y8uG, 0.5107, 3.38, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
605, 3a7uA, 0.5107, 3.37, 0.079, 243, 76, CRYSTAL STRUCTURE OF THE BOVINE LIPOYLTRANSFERASE IN ITS UNLIGANDED FORM
606, 6g8nU, 0.5106, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH CYSTARGOLIDE B DERIVATIVE 2 
607, 6g8nG, 0.5106, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH CYSTARGOLIDE B DERIVATIVE 2 
608, 5cz5U, 0.5106, 3.38, 0.079, 241, 76, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
609, 5cz5G, 0.5106, 3.38, 0.079, 241, 76, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
610, 3mg4Z, 0.5106, 3.43, 0.053, 325, 75, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
611, 4ya3U, 0.5105, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
612, 4y6zU, 0.5105, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
613, 4y6zG, 0.5105, 3.37, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
614, 6epe7, 0.5104, 3.37, 0.079, 241, 76, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
615, 5vfsM, 0.5104, 3.70, 0.067, 222, 75, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
616, 5vfrS, 0.5104, 3.39, 0.079, 241, 76, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
617, 4ya3G, 0.5104, 3.38, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
618, 4qw3U, 0.5104, 3.38, 0.079, 241, 76, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
619, 4qw3G, 0.5104, 4.36, 0.036, 216, 83, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
620, 4qbyG, 0.5104, 3.72, 0.091, 213, 77, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
621, 4cr26, 0.5104, 4.23, 0.123, 215, 81, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
622, 1g65F, 0.5104, 3.66, 0.091, 213, 77, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
623, 4y6aU, 0.5103, 3.39, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
624, 4qbyU, 0.5103, 3.39, 0.079, 241, 76, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
625, 4y6aG, 0.5102, 3.39, 0.079, 241, 76, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
626, 4v1vA, 0.5101, 3.36, 0.079, 241, 76, HETEROCYCLASE IN COMPLEX WITH SUBSTRATE AND COFACTOR
627, 1g0uG, 0.5100, 3.80, 0.080, 222, 75, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
628, 4qwsU, 0.5099, 3.97, 0.025, 244, 79, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
629, 4qwsG, 0.5099, 3.38, 0.079, 241, 76, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
630, 6hw5U, 0.5098, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 18 
631, 6hw5G, 0.5098, 3.38, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 18 
632, 4v1tB, 0.5097, 4.10, 0.086, 747, 81, HETEROCYCLASE IN COMPLEX WITH SUBSTRATE AND COFACTOR
633, 4tvyB, 0.5097, 3.37, 0.079, 240, 76, APO RESORUFIN LIGASE
634, 5vfsLA, 0.5096, 3.38, 0.079, 241, 76, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
635, 4u39A, 0.5096, 3.38, 0.079, 241, 76, CRYSTAL STRUCTURE OF FTSZ:MCIZ COMPLEX FROM BACILLUS SUBTILIS
636, 4inrL, 0.5096, 3.40, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
637, 5le5Z, 0.5093, 3.40, 0.079, 241, 76, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
638, 5a5b6, 0.5093, 4.06, 0.085, 753, 82, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
639, 4qwgU, 0.5093, 3.73, 0.103, 321, 78, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
640, 4qwgG, 0.5093, 3.68, 0.091, 213, 77, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
641, 4hnpG, 0.5093, 3.81, 0.073, 294, 82, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
642, 4cr36, 0.5093, 3.71, 0.080, 222, 75, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
643, 6j2xO, 0.5091, 4.05, 0.100, 213, 80, struct.pdbx_descriptor              
644, 6hv4L, 0.5090, 3.96, 0.051, 222, 78, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH ONX 0914 
645, 4hrcG, 0.5090, 3.40, 0.079, 241, 76, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
646, 6hvvL, 0.5089, 3.40, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 39 
647, 6gopL, 0.5088, 3.40, 0.079, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
648, 6dkeA, 0.5088, 3.96, 0.051, 222, 78, THE X-RAY CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE FATTY ACID KINASE (FAK) B1 PROTEIN LOADED WITH PALMITIC ACID (C16:0) TO 1.76 ANGSTROM RESOLUTION 
649, 1jd2S, 0.5088, 3.43, 0.105, 243, 76, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
650, 6gopZ, 0.5087, 3.75, 0.079, 222, 76, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
651, 6gopT, 0.5087, 3.40, 0.079, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
652, 4qz2Z, 0.5087, 3.73, 0.080, 222, 75, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
653, 4qz0Z, 0.5087, 3.70, 0.067, 222, 75, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
654, 4qwuZ, 0.5087, 3.59, 0.069, 283, 72, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
655, 2e5aA, 0.5087, 3.71, 0.067, 222, 75, CRYSTAL STRUCTURE OF BOVINE LIPOYLTRANSFERASE IN COMPLEX WITH LIPOYL-AMP
656, 4u39E, 0.5086, 3.70, 0.067, 222, 75, CRYSTAL STRUCTURE OF FTSZ:MCIZ COMPLEX FROM BACILLUS SUBTILIS
657, 4qz0L, 0.5086, 3.99, 0.025, 243, 79, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
658, 3jcpP, 0.5086, 3.69, 0.067, 222, 75, 
659, 3gpj1, 0.5086, 3.69, 0.067, 222, 75, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
660, 5nifO, 0.5085, 3.69, 0.080, 222, 75, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
661, 4u39F, 0.5085, 3.49, 0.054, 329, 74, CRYSTAL STRUCTURE OF FTSZ:MCIZ COMPLEX FROM BACILLUS SUBTILIS
662, 3jcpPA, 0.5085, 3.77, 0.073, 286, 82, 
663, 3gpjM, 0.5085, 3.69, 0.067, 222, 75, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
664, 6hvsM, 0.5084, 4.01, 0.064, 244, 78, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 18 
665, 6huca, 0.5084, 4.01, 0.064, 244, 78, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 18 
666, 3wxrM, 0.5084, 3.95, 0.115, 233, 78, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
667, 6hvsa, 0.5083, 3.36, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 18 
668, 6hucM, 0.5083, 3.82, 0.085, 284, 82, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 18 
669, 4u39C, 0.5083, 4.01, 0.064, 244, 78, CRYSTAL STRUCTURE OF FTSZ:MCIZ COMPLEX FROM BACILLUS SUBTILIS
670, 4qwuL, 0.5083, 3.95, 0.115, 233, 78, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
671, 3oeuL, 0.5083, 4.18, 0.086, 233, 81, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
672, 3jcoPA, 0.5083, 4.08, 0.087, 224, 80, 
673, 5mp9a, 0.5082, 3.80, 0.066, 222, 76, 26S PROTEASOME IN PRESENCE OF ATP (S1)
674, 5l5pL, 0.5082, 4.18, 0.086, 233, 81, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
675, 6msdUA, 0.5081, 4.08, 0.087, 224, 80, struct.pdbx_descriptor               26S proteasome  
676, 6huqa, 0.5081, 3.91, 0.071, 288, 84, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 20 
677, 6fvwM, 0.5081, 3.69, 0.080, 222, 75, struct.pdbx_descriptor              
678, 5mpcO, 0.5081, 3.59, 0.068, 222, 74, 
679, 5bxnL, 0.5081, 3.78, 0.026, 244, 78, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
680, 4v1vB, 0.5081, 3.40, 0.079, 241, 76, HETEROCYCLASE IN COMPLEX WITH SUBSTRATE AND COFACTOR
681, 4qz1L, 0.5081, 3.83, 0.066, 222, 76, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
682, 4lqiL, 0.5081, 3.70, 0.078, 213, 77, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
683, 4fzga, 0.5081, 4.08, 0.087, 224, 80, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
684, 3jcoP, 0.5081, 3.78, 0.067, 222, 75, 
685, 6fvwAA, 0.5080, 3.26, 0.080, 241, 75, struct.pdbx_descriptor              
686, 5bxnZ, 0.5080, 3.71, 0.067, 222, 75, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
687, 4inuZ, 0.5080, 4.07, 0.085, 747, 82, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
688, 4fzgM, 0.5080, 3.70, 0.067, 222, 75, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
689, 3mg6Z, 0.5080, 3.72, 0.067, 222, 75, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
690, 4v1uA, 0.5079, 3.96, 0.115, 233, 78, HETEROCYCLASE IN COMPLEX WITH SUBSTRATE AND COFACTOR
691, 4qvlZ, 0.5079, 3.78, 0.026, 244, 78, YCP IN COMPLEX WITH BORTEZOMIB
692, 4qvlL, 0.5079, 3.78, 0.026, 244, 78, YCP IN COMPLEX WITH BORTEZOMIB
693, 6hw4L, 0.5078, 3.91, 0.065, 222, 77, YEAST 20S PROTEASOME IN COMPLEX WITH 16 
694, 6huqM, 0.5078, 3.71, 0.067, 222, 75, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 20 
695, 4qv0L, 0.5078, 3.57, 0.054, 222, 74, YCP BETA5-A49T-A50V-DOUBLE MUTANT
696, 4j70L, 0.5078, 3.96, 0.115, 233, 78, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
697, 6hw4Z, 0.5077, 3.75, 0.066, 222, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 16 
698, 6hubL, 0.5077, 4.06, 0.085, 746, 82, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 16 
699, 5vfuSA, 0.5077, 3.72, 0.080, 222, 75, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
700, 5vftt, 0.5077, 3.71, 0.080, 222, 75, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
701, 4j70Z, 0.5077, 3.71, 0.067, 222, 75, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
702, 3unen, 0.5077, 4.08, 0.087, 224, 80, MOUSE CONSTITUTIVE 20S PROTEASOME
703, 6hubZ, 0.5076, 3.71, 0.080, 222, 75, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 16 
704, 6gopa, 0.5076, 3.73, 0.067, 222, 75, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
705, 4qwrZ, 0.5076, 3.71, 0.067, 222, 75, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
706, 4qv0Z, 0.5076, 3.71, 0.067, 222, 75, YCP BETA5-A49T-A50V-DOUBLE MUTANT
707, 6fvxG, 0.5075, 4.25, 0.123, 215, 81, struct.pdbx_descriptor              
708, 5l5yZ, 0.5075, 4.25, 0.123, 215, 81, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
709, 5l5yL, 0.5075, 3.73, 0.067, 222, 75, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
710, 4qv0a, 0.5075, 3.70, 0.091, 213, 77, YCP BETA5-A49T-A50V-DOUBLE MUTANT
711, 6hvwa, 0.5074, 3.71, 0.067, 222, 75, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 43 
712, 4y8ra, 0.5074, 4.10, 0.087, 233, 80, YEAST 20S PROTEASOME BETA2-H116D MUTANT
713, 4qxjZ, 0.5074, 3.72, 0.067, 222, 75, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
714, 6hvwM, 0.5073, 3.71, 0.080, 222, 75, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 43 
715, 6huva, 0.5073, 3.89, 0.026, 244, 78, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 39 
716, 6fvwO, 0.5073, 3.92, 0.065, 222, 77, struct.pdbx_descriptor              
717, 5fgeZ, 0.5073, 3.92, 0.065, 222, 77, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
718, 4ya4a, 0.5073, 4.10, 0.087, 233, 80, YEAST 20S PROTEASOME BETA2-H114D MUTANT
719, 4y8rM, 0.5073, 4.10, 0.087, 233, 80, YEAST 20S PROTEASOME BETA2-H116D MUTANT
720, 4qw0L, 0.5073, 4.09, 0.087, 233, 80, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
721, 6j2qN, 0.5072, 3.71, 0.067, 222, 75, struct.pdbx_descriptor              
722, 5l69Z, 0.5072, 4.10, 0.087, 233, 80, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
723, 5l5pZ, 0.5072, 4.09, 0.087, 224, 80, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
724, 5d0sZ, 0.5072, 3.43, 0.079, 244, 76, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
725, 5cz5Z, 0.5072, 3.93, 0.065, 222, 77, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
726, 4y81L, 0.5072, 4.09, 0.087, 232, 80, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
727, 4qvyL, 0.5072, 4.09, 0.087, 233, 80, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
728, 3bdmM, 0.5072, 3.84, 0.066, 222, 76, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
729, 6hwaZ, 0.5071, 4.07, 0.101, 233, 79, YEAST 20S PROTEASOME IN COMPLEX WITH 43 
730, 6hwaL, 0.5071, 3.71, 0.067, 222, 75, YEAST 20S PROTEASOME IN COMPLEX WITH 43 
731, 6hvua, 0.5071, 3.72, 0.067, 222, 75, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 29 
732, 6hv4M, 0.5071, 3.89, 0.065, 222, 77, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH ONX 0914 
733, 6htpa, 0.5071, 3.74, 0.080, 222, 75, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 7 
734, 6fvwA, 0.5071, 3.73, 0.080, 222, 75, struct.pdbx_descriptor              
735, 4ya4M, 0.5071, 3.73, 0.067, 222, 75, YEAST 20S PROTEASOME BETA2-H114D MUTANT
736, 4qvyZ, 0.5071, 4.12, 0.087, 233, 80, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
737, 6huvM, 0.5070, 3.71, 0.067, 222, 75, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 39 
738, 5l69L, 0.5070, 3.71, 0.067, 222, 75, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
739, 4qvmL, 0.5070, 4.20, 0.086, 233, 81, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
740, 1jd21, 0.5070, 4.09, 0.087, 222, 80, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
741, 6hv4a, 0.5069, 4.09, 0.087, 224, 80, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH ONX 0914 
742, 6htpM, 0.5069, 3.91, 0.065, 222, 77, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 7 
743, 6gopM, 0.5069, 3.46, 0.079, 244, 76, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
744, 5vfsMA, 0.5069, 4.09, 0.087, 229, 80, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
745, 4qzzL, 0.5069, 3.73, 0.067, 222, 75, YCP IN COMPLEX WITH OMURALIDE
746, 4qzwL, 0.5069, 4.10, 0.087, 224, 80, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
747, 4qw0Z, 0.5069, 3.72, 0.067, 222, 75, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
748, 4qv6a, 0.5069, 3.72, 0.067, 222, 75, YCP BETA5-A49V MUTANT
749, 2x3jA, 0.5069, 3.71, 0.013, 244, 76, CO-COMPLEX STRUCTURE OF ACHROMOBACTIN SYNTHETASE PROTEIN D (ACSD) WITH ATP AND N-CITRYL-ETHYLENEDIAMINE FROM PECTOBACTERIUM CHRYSANTHEMI
750, 4ya4Z, 0.5068, 4.09, 0.087, 222, 80, YEAST 20S PROTEASOME BETA2-H114D MUTANT
751, 4ya4L, 0.5068, 4.10, 0.087, 224, 80, YEAST 20S PROTEASOME BETA2-H114D MUTANT
752, 4x6zM, 0.5068, 4.09, 0.087, 233, 80, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
753, 4qzzZ, 0.5068, 4.23, 0.123, 215, 81, YCP IN COMPLEX WITH OMURALIDE
754, 4qzwZ, 0.5068, 3.73, 0.067, 222, 75, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
755, 4qwsZ, 0.5068, 3.72, 0.067, 222, 75, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
756, 4qwsL, 0.5068, 3.73, 0.067, 222, 75, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
757, 4qv6M, 0.5068, 4.13, 0.086, 233, 81, YCP BETA5-A49V MUTANT
758, 3bdm0, 0.5068, 4.07, 0.024, 586, 82, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
759, 6huua, 0.5067, 3.72, 0.067, 222, 75, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 29 
760, 6huuM, 0.5067, 3.72, 0.067, 222, 75, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 29 
761, 3okjZ, 0.5067, 3.78, 0.093, 222, 75, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
762, 3nzjL, 0.5067, 3.73, 0.067, 222, 75, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
763, 1g0uT, 0.5067, 3.72, 0.067, 222, 75, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
764, 4qwgL, 0.5066, 3.73, 0.080, 222, 75, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
765, 4qw6Z, 0.5066, 3.73, 0.080, 222, 75, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
766, 4qw6L, 0.5066, 4.13, 0.086, 233, 81, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
767, 6g7fZ, 0.5065, 4.12, 0.087, 233, 80, YEAST 20S PROTEASOME IN COMPLEX WITH CYSTARGOLIDE B 
768, 5l5sL, 0.5065, 4.10, 0.087, 224, 80, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
769, 5ey1A, 0.5065, 4.10, 0.087, 224, 80, CRYSTAL STRUCTURE OF CODY FROM STAPHYLOCOCCUS AUREUS WITH GTP AND ILE
770, 5d0xL, 0.5065, 3.71, 0.067, 221, 75, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
771, 5d0wL, 0.5065, 3.60, 0.054, 222, 74, YEAST 20S PROTEASOME BETA5-T1S MUTANT
772, 4qv8L, 0.5065, 3.66, 0.013, 242, 76, YCP BETA5-C52F MUTANT
773, 6fvuAA, 0.5064, 3.74, 0.080, 222, 75, struct.pdbx_descriptor              
774, 5l63L, 0.5064, 3.85, 0.065, 222, 77, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
775, 5l5oZ, 0.5064, 3.85, 0.065, 222, 77, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
776, 5d0xZ, 0.5064, 3.73, 0.067, 222, 75, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
777, 5d0wZ, 0.5064, 3.72, 0.067, 222, 75, YEAST 20S PROTEASOME BETA5-T1S MUTANT
778, 4qv8Z, 0.5064, 3.82, 0.025, 240, 79, YCP BETA5-C52F MUTANT
779, 6qm7U, 0.5063, 3.72, 0.067, 222, 75, LEISHMANIA TARENTOLAE PROTEASOME 20S SUBUNIT COMPLEXED WITH GSK3494245 
780, 6fvxA, 0.5063, 3.76, 0.080, 222, 75, struct.pdbx_descriptor              
781, 5l63Z, 0.5063, 3.73, 0.067, 222, 75, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
782, 4qw5Z, 0.5063, 4.05, 0.064, 222, 78, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
783, 4qw5L, 0.5063, 3.72, 0.067, 222, 75, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
784, 4qv5Z, 0.5063, 3.73, 0.067, 222, 75, YCP BETA5-M45I MUTANT
785, 4qv5L, 0.5063, 3.72, 0.067, 222, 75, YCP BETA5-M45I MUTANT
786, 4gk7a, 0.5063, 3.76, 0.080, 222, 75, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
787, 4cr46, 0.5063, 3.73, 0.067, 222, 75, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
788, 6j30M, 0.5062, 3.86, 0.078, 228, 77, struct.pdbx_descriptor              
789, 6hw5Z, 0.5062, 3.45, 0.079, 242, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 18 
790, 5nglB, 0.5062, 4.00, 0.039, 222, 77, THE ENDO-BETA16-GLUCANASE BT3312
791, 5l6cL, 0.5062, 3.72, 0.067, 222, 75, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
792, 5fgaM, 0.5062, 3.86, 0.065, 222, 77, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
793, 5ey0B, 0.5062, 3.86, 0.065, 222, 77, CRYSTAL STRUCTURE OF CODY FROM STAPHYLOCOCCUS AUREUS WITH GTP AND ILE
794, 4y8rL, 0.5062, 3.73, 0.080, 222, 75, YEAST 20S PROTEASOME BETA2-H116D MUTANT
795, 4v1uB, 0.5062, 3.73, 0.080, 222, 75, HETEROCYCLASE IN COMPLEX WITH SUBSTRATE AND COFACTOR
796, 4qv1Z, 0.5062, 4.23, 0.086, 233, 81, YCP BETA5-M45A MUTANT
797, 4q1sF, 0.5062, 3.84, 0.052, 222, 77, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
798, 3shj1, 0.5062, 3.96, 0.091, 222, 77, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
799, 2zcyM, 0.5062, 3.73, 0.080, 222, 75, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
800, 2zcy0, 0.5062, 3.87, 0.063, 454, 79, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
801, 2w02B, 0.5062, 3.73, 0.067, 222, 75, CO-COMPLEX STRUCTURE OF ACHROMOBACTIN SYNTHETASE PROTEIN D ( ACSD) WITH ATP FROM PECTOBACTERIUM CHRYSANTHEMI
802, 6fvvO, 0.5061, 4.11, 0.087, 233, 80, struct.pdbx_descriptor              
803, 5vfsN, 0.5061, 3.84, 0.025, 253, 79, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
804, 5l5ra, 0.5061, 3.72, 0.067, 222, 75, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
805, 4qv1L, 0.5061, 4.07, 0.085, 743, 82, YCP BETA5-M45A MUTANT
806, 4quyZ, 0.5061, 3.73, 0.080, 222, 75, YCP BETA5-A49S-MUTANT
807, 4quyL, 0.5061, 3.66, 0.013, 244, 76, YCP BETA5-A49S-MUTANT
808, 4qluZ, 0.5061, 4.01, 0.089, 233, 79, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
809, 4qluL, 0.5061, 3.97, 0.115, 233, 78, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
810, 6htdM, 0.5060, 3.97, 0.115, 233, 78, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 4 
811, 5l6cZ, 0.5060, 4.03, 0.024, 579, 82, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
812, 5l66Z, 0.5060, 3.46, 0.091, 241, 77, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
813, 5l5rM, 0.5060, 4.24, 0.123, 215, 81, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
814, 5d0wa, 0.5060, 4.12, 0.075, 233, 80, YEAST 20S PROTEASOME BETA5-T1S MUTANT
815, 4y81Z, 0.5060, 3.73, 0.080, 222, 75, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
816, 4j70T, 0.5060, 3.74, 0.067, 222, 75, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
817, 4gk7M, 0.5060, 3.74, 0.067, 222, 75, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
818, 6g7fa, 0.5059, 3.78, 0.079, 222, 76, YEAST 20S PROTEASOME IN COMPLEX WITH CYSTARGOLIDE B 
819, 6fvtM, 0.5059, 3.78, 0.079, 222, 76, struct.pdbx_descriptor              
820, 5vfot, 0.5059, 4.11, 0.087, 224, 80, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
821, 5l66L, 0.5059, 3.73, 0.067, 222, 75, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
822, 5l5tZ, 0.5059, 3.72, 0.067, 222, 75, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
823, 5fghZ, 0.5059, 4.12, 0.075, 233, 80, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
824, 5fghL, 0.5059, 4.14, 0.086, 233, 81, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
825, 5d0wM, 0.5059, 3.61, 0.068, 222, 74, YEAST 20S PROTEASOME BETA5-T1S MUTANT
826, 4y8rZ, 0.5059, 3.68, 0.013, 244, 76, YEAST 20S PROTEASOME BETA2-H116D MUTANT
827, 4x6zG, 0.5059, 4.23, 0.086, 233, 81, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
828, 4tvyA, 0.5059, 4.10, 0.087, 232, 80, APO RESORUFIN LIGASE
829, 4qv0M, 0.5059, 3.98, 0.078, 222, 77, YCP BETA5-A49T-A50V-DOUBLE MUTANT
830, 3un4a, 0.5059, 4.34, 0.122, 215, 82, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
831, 6hubM, 0.5058, 3.73, 0.067, 222, 75, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 16 
832, 6fvtAA, 0.5058, 3.72, 0.067, 222, 75, struct.pdbx_descriptor              
833, 4qw3Z, 0.5058, 3.73, 0.080, 222, 75, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
834, 4qw3L, 0.5058, 3.73, 0.080, 222, 75, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
835, 4qv4L, 0.5058, 4.14, 0.086, 233, 81, YCP BETA5-M45T MUTANT
836, 4qv3a, 0.5058, 3.72, 0.067, 222, 75, YCP BETA5-M45V MUTANT
837, 4qluT, 0.5058, 3.75, 0.013, 244, 77, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
838, 5l5jL, 0.5057, 3.74, 0.103, 329, 78, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
839, 5l5fZ, 0.5057, 4.15, 0.086, 233, 81, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
840, 5l5fL, 0.5057, 4.00, 0.089, 233, 79, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
841, 4v7oA, 0.5057, 4.11, 0.087, 224, 80, 
842, 4qv4Z, 0.5057, 3.92, 0.065, 222, 77, YCP BETA5-M45T MUTANT
843, 1g65M, 0.5057, 3.73, 0.080, 222, 75, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
844, 6hvrM, 0.5056, 3.73, 0.080, 222, 75, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 16 
845, 6htda, 0.5056, 3.74, 0.080, 222, 75, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 4 
846, 5ngkA, 0.5056, 4.13, 0.087, 233, 80, THE ENDO-BETA16-GLUCANASE BT3312
847, 5cz7L, 0.5056, 3.67, 0.013, 243, 76, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
848, 4y84F, 0.5056, 3.75, 0.067, 222, 75, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
849, 4quyM, 0.5056, 3.95, 0.065, 222, 77, YCP BETA5-A49S-MUTANT
850, 3gpjT, 0.5056, 3.95, 0.065, 222, 77, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
851, 3e471, 0.5056, 3.39, 0.079, 243, 76, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
852, 3dy3F, 0.5056, 3.74, 0.080, 222, 75, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
853, 6hvuT, 0.5055, 4.12, 0.087, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 29 
854, 6hvra, 0.5055, 4.22, 0.086, 233, 81, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 16 
855, 6hucF, 0.5055, 4.10, 0.087, 224, 80, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 18 
856, 6gopF, 0.5055, 3.85, 0.038, 458, 79, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
857, 5l5dZ, 0.5055, 3.73, 0.067, 222, 75, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
858, 5cz7Z, 0.5055, 3.67, 0.013, 243, 76, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
859, 4y8gF, 0.5055, 4.00, 0.089, 233, 79, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
860, 4qluF, 0.5055, 3.67, 0.013, 244, 76, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
861, 4q1sM, 0.5055, 4.00, 0.114, 233, 79, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
862, 3e47M, 0.5055, 3.66, 0.013, 244, 76, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
863, 3dy3T, 0.5055, 3.66, 0.013, 243, 76, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
864, 3dy3L, 0.5055, 4.22, 0.086, 233, 81, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
865, 6hvuF, 0.5054, 3.65, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 29 
866, 5vfuEA, 0.5054, 3.66, 0.013, 243, 76, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
867, 5vftT, 0.5054, 3.73, 0.067, 222, 75, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
868, 5nifM, 0.5054, 3.73, 0.067, 222, 75, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
869, 5l61Z, 0.5054, 3.67, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
870, 5l5wL, 0.5054, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
871, 5l5dL, 0.5054, 4.13, 0.086, 233, 81, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
872, 5bxlL, 0.5054, 4.00, 0.114, 233, 79, YEAST 20S PROTEASOME BETA2-G170A MUTANT
873, 4r17M, 0.5054, 3.66, 0.013, 244, 76, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
874, 4r00L, 0.5054, 3.99, 0.064, 222, 78, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
875, 4qz4Z, 0.5054, 3.66, 0.013, 243, 76, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
876, 4qz4L, 0.5054, 4.26, 0.123, 215, 81, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
877, 4qv9a, 0.5054, 4.26, 0.123, 215, 81, YCP BETA5-C63F MUTANT
878, 4qv9M, 0.5054, 3.91, 0.091, 222, 77, YCP BETA5-C63F MUTANT
879, 4j70F, 0.5054, 3.82, 0.066, 222, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
880, 4g4sN, 0.5054, 3.93, 0.065, 222, 77, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
881, 4g4sM, 0.5054, 3.73, 0.067, 222, 75, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
882, 6hv5a, 0.5053, 3.73, 0.067, 222, 75, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 4 
883, 6hv5M, 0.5053, 4.10, 0.087, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 4 
884, 6hv4T, 0.5053, 3.74, 0.080, 222, 75, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH ONX 0914 
885, 6hucT, 0.5053, 3.87, 0.078, 222, 77, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 18 
886, 6fvyM, 0.5053, 3.87, 0.078, 222, 77, struct.pdbx_descriptor              
887, 6fvvAA, 0.5053, 4.03, 0.075, 233, 80, struct.pdbx_descriptor              
888, 5nifG, 0.5053, 4.03, 0.075, 233, 80, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
889, 5mpbA, 0.5053, 3.68, 0.013, 244, 76, 
890, 5l6bZ, 0.5053, 4.11, 0.100, 233, 80, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
891, 5l6bL, 0.5053, 4.01, 0.064, 222, 78, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
892, 5l6aM, 0.5053, 4.11, 0.087, 233, 80, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
893, 5l5wZ, 0.5053, 4.11, 0.087, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
894, 5l5rZ, 0.5053, 3.66, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
895, 5l5rL, 0.5053, 3.65, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
896, 5fgdZ, 0.5053, 3.80, 0.066, 222, 76, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
897, 5fgdL, 0.5053, 3.85, 0.053, 222, 76, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
898, 5bxlZ, 0.5053, 3.71, 0.013, 244, 76, YEAST 20S PROTEASOME BETA2-G170A MUTANT
899, 4zzgM, 0.5053, 3.23, 0.080, 241, 75, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
900, 4y8hT, 0.5053, 3.95, 0.065, 222, 77, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
901, 4y8hF, 0.5053, 3.95, 0.065, 222, 77, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
902, 4y8gT, 0.5053, 4.12, 0.087, 233, 80, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
903, 4x6zU, 0.5053, 3.93, 0.065, 222, 77, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
904, 4qv9T, 0.5053, 3.74, 0.067, 222, 75, YCP BETA5-C63F MUTANT
905, 4qv9F, 0.5053, 3.74, 0.067, 222, 75, YCP BETA5-C63F MUTANT
906, 4qv6T, 0.5053, 3.74, 0.080, 222, 75, YCP BETA5-A49V MUTANT
907, 4qv6F, 0.5053, 3.74, 0.080, 222, 75, YCP BETA5-A49V MUTANT
908, 4nnnT, 0.5053, 3.73, 0.067, 222, 75, YCP IN COMPLEX WITH MG132
909, 3e47F, 0.5053, 3.92, 0.091, 222, 77, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
910, 3dy3Z, 0.5053, 3.69, 0.013, 243, 76, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
911, 1fntA, 0.5053, 3.69, 0.013, 243, 76, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
912, 5vfpN, 0.5052, 3.69, 0.013, 243, 76, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
913, 5l64L, 0.5052, 3.65, 0.013, 244, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
914, 5l61L, 0.5052, 3.66, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
915, 5l5uT, 0.5052, 3.66, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
916, 5l5uF, 0.5052, 3.65, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
917, 5fggT, 0.5052, 3.65, 0.013, 243, 76, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
918, 5fggF, 0.5052, 3.67, 0.013, 243, 76, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
919, 5fgaT, 0.5052, 3.78, 0.013, 244, 77, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
920, 5fgaF, 0.5052, 4.00, 0.064, 222, 78, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
921, 4zzg2, 0.5052, 3.39, 0.079, 238, 76, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
922, 4ya9F, 0.5052, 4.36, 0.122, 215, 82, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
923, 4r17a, 0.5052, 3.95, 0.065, 222, 77, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
924, 4qwuF, 0.5052, 3.82, 0.066, 222, 76, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
925, 4qlsT, 0.5052, 3.66, 0.013, 243, 76, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
926, 4nnnF, 0.5052, 3.66, 0.013, 243, 76, YCP IN COMPLEX WITH MG132
927, 1rypU, 0.5052, 3.67, 0.013, 243, 76, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
928, 1fntO, 0.5052, 3.67, 0.013, 243, 76, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
929, 6hvsT, 0.5051, 3.67, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 18 
930, 6hv4F, 0.5051, 3.67, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH ONX 0914 
931, 6huqF, 0.5051, 4.15, 0.087, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 20 
932, 6fvtO, 0.5051, 3.67, 0.013, 243, 76, struct.pdbx_descriptor              
933, 5l65L, 0.5051, 4.11, 0.087, 233, 80, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
934, 5l64Z, 0.5051, 3.67, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
935, 5l5iL, 0.5051, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
936, 5fg7M, 0.5051, 3.67, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-T1A MUTANT
937, 5ahja, 0.5051, 3.65, 0.013, 244, 76, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
938, 5ahjM, 0.5051, 3.39, 0.079, 238, 76, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
939, 4ya1Z, 0.5051, 3.66, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-H116N MUTANT
940, 4y8rT, 0.5051, 3.67, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-H116D MUTANT
941, 4quxZ, 0.5051, 3.66, 0.013, 243, 76, YCP BETA5-A49T-MUTANT
942, 4qlvT, 0.5051, 3.55, 0.065, 241, 77, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
943, 4qlsF, 0.5051, 3.73, 0.067, 222, 75, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
944, 4nnwZ, 0.5051, 3.95, 0.065, 222, 77, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
945, 3d29T, 0.5051, 3.74, 0.067, 222, 75, PROTEASOME INHIBITION BY FELLUTAMIDE B
946, 2x3kA, 0.5051, 4.12, 0.087, 233, 80, CO-COMPLEX STRUCTURE OF ACHROMOBACTIN SYNTHETASE PROTEIN D ( ACSD) WITH AMP AND SULFATE FROM PECTOBACTERIUM CHRYSANTHEMI
947, 1ryp2, 0.5051, 4.01, 0.089, 233, 79, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
948, 6j30G, 0.5050, 4.01, 0.089, 233, 79, struct.pdbx_descriptor              
949, 6hwcL, 0.5050, 3.75, 0.067, 222, 75, YEAST 20S PROTEASOME BETA2-G45A MUTANT 
950, 6huqT, 0.5050, 3.66, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 20 
951, 6fvwG, 0.5050, 3.74, 0.067, 222, 75, struct.pdbx_descriptor              
952, 6epcB, 0.5050, 3.69, 0.013, 243, 76, GROUND STATE 26S PROTEASOME (GS2)
953, 5m2bZ, 0.5050, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
954, 5m2bL, 0.5050, 3.79, 0.079, 222, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
955, 5l6aL, 0.5050, 3.66, 0.013, 244, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
956, 5l62Z, 0.5050, 4.07, 0.024, 575, 82, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
957, 5l5jZ, 0.5050, 4.11, 0.087, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
958, 5l5aZ, 0.5050, 4.15, 0.101, 229, 79, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
959, 5bouZ, 0.5050, 3.76, 0.067, 222, 75, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
960, 4ya9T, 0.5050, 3.67, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
961, 4ya4T, 0.5050, 3.70, 0.013, 245, 76, YEAST 20S PROTEASOME BETA2-H114D MUTANT
962, 4ya4F, 0.5050, 3.89, 0.051, 234, 79, YEAST 20S PROTEASOME BETA2-H114D MUTANT
963, 4ya2T, 0.5050, 3.75, 0.067, 222, 75, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
964, 4ya2F, 0.5050, 3.75, 0.067, 222, 75, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
965, 4y8rF, 0.5050, 3.61, 0.054, 222, 74, YEAST 20S PROTEASOME BETA2-H116D MUTANT
966, 4qwuT, 0.5050, 3.82, 0.066, 222, 76, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
967, 4quxL, 0.5050, 3.74, 0.067, 222, 75, YCP BETA5-A49T-MUTANT
968, 4qlvF, 0.5050, 3.75, 0.067, 222, 75, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
969, 4qltF, 0.5050, 3.75, 0.067, 222, 75, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
970, 3une3, 0.5050, 3.67, 0.013, 243, 76, MOUSE CONSTITUTIVE 20S PROTEASOME
971, 3mg4L, 0.5050, 3.67, 0.013, 243, 76, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
972, 3e47T, 0.5050, 3.67, 0.013, 243, 76, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
973, 6hv3L, 0.5049, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) 
974, 6htbL, 0.5049, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) 
975, 5bxnF, 0.5049, 3.66, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
976, 4y9zF, 0.5049, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
977, 4qz6M, 0.5049, 3.77, 0.067, 222, 75, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
978, 4qwua, 0.5049, 3.69, 0.013, 243, 76, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
979, 4qwuM, 0.5049, 3.66, 0.013, 243, 76, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
980, 4qwlT, 0.5049, 4.41, 0.122, 216, 82, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
981, 4qwlF, 0.5049, 4.04, 0.064, 222, 78, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
982, 4quya, 0.5049, 3.68, 0.013, 244, 76, YCP BETA5-A49S-MUTANT
983, 4qltT, 0.5049, 3.76, 0.067, 222, 75, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
984, 3hyeF, 0.5049, 3.74, 0.067, 222, 75, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
985, 1rypG, 0.5049, 3.67, 0.013, 243, 76, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
986, 1jd22, 0.5049, 3.67, 0.013, 243, 76, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
987, 6hwfT, 0.5048, 4.11, 0.087, 233, 80, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH ONX 0914 
988, 6hwcZ, 0.5048, 4.05, 0.075, 233, 80, YEAST 20S PROTEASOME BETA2-G45A MUTANT 
989, 6hvtT, 0.5048, 4.05, 0.075, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 20 
990, 6hvtF, 0.5048, 3.67, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 20 
991, 6huuT, 0.5048, 3.67, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 29 
992, 6huuF, 0.5048, 4.04, 0.075, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 29 
993, 6htdT, 0.5048, 3.66, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 4 
994, 6htbZ, 0.5048, 3.66, 0.013, 244, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) 
995, 5l67L, 0.5048, 3.67, 0.013, 244, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
996, 5l65Z, 0.5048, 3.45, 0.079, 243, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
997, 5l62L, 0.5048, 3.67, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
998, 5l5uM, 0.5048, 3.76, 0.067, 222, 75, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
999, 5l5iZ, 0.5048, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1000, 5jhrT, 0.5048, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1001, 5jhrF, 0.5048, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1002, 5fgaa, 0.5048, 3.67, 0.013, 243, 76, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1003, 5fg7a, 0.5048, 3.67, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1004, 5fg7T, 0.5048, 3.74, 0.067, 222, 75, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1005, 5bxnT, 0.5048, 3.61, 0.054, 222, 74, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1006, 5bouL, 0.5048, 3.73, 0.067, 222, 75, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1007, 4ya7T, 0.5048, 3.82, 0.066, 222, 76, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1008, 4ya7F, 0.5048, 4.15, 0.086, 233, 81, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1009, 4u39D, 0.5048, 3.74, 0.067, 222, 75, CRYSTAL STRUCTURE OF FTSZ:MCIZ COMPLEX FROM BACILLUS SUBTILIS
1010, 4qz6a, 0.5048, 3.67, 0.013, 243, 76, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1011, 4quyT, 0.5048, 3.67, 0.013, 243, 76, YCP BETA5-A49S-MUTANT
1012, 4quyF, 0.5048, 4.15, 0.086, 232, 81, YCP BETA5-A49S-MUTANT
1013, 3shjM, 0.5048, 4.01, 0.089, 233, 79, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1014, 3dy4M, 0.5048, 3.79, 0.013, 243, 77, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1015, 3dy41, 0.5048, 3.67, 0.013, 243, 76, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1016, 6hwfF, 0.5047, 3.74, 0.067, 222, 75, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH ONX 0914 
1017, 6hvsF, 0.5047, 3.67, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 18 
1018, 6hv7F, 0.5047, 3.67, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 7 
1019, 6hv3Z, 0.5047, 3.83, 0.048, 280, 83, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) 
1020, 6htdF, 0.5047, 4.11, 0.087, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 4 
1021, 6fvtA, 0.5047, 3.67, 0.013, 243, 76, struct.pdbx_descriptor              
1022, 5nifN, 0.5047, 3.67, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1023, 5l6bM, 0.5047, 4.05, 0.075, 233, 80, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1024, 5l5rT, 0.5047, 4.04, 0.089, 233, 79, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1025, 5l5rF, 0.5047, 4.03, 0.089, 233, 79, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1026, 5fg7F, 0.5047, 3.67, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1027, 5czaT, 0.5047, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1028, 5cz8F, 0.5047, 3.67, 0.013, 243, 76, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1029, 4y9zT, 0.5047, 3.76, 0.067, 222, 75, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1030, 4y8pT, 0.5047, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1031, 4y8pF, 0.5047, 3.92, 0.065, 222, 77, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1032, 4qlta, 0.5047, 3.46, 0.079, 241, 76, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1033, 4no9T, 0.5047, 4.04, 0.089, 232, 79, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1034, 4nnwT, 0.5047, 4.13, 0.087, 233, 80, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1035, 4nnwF, 0.5047, 3.67, 0.013, 243, 76, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1036, 3wxrN, 0.5047, 3.67, 0.013, 243, 76, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1037, 3unba, 0.5047, 3.79, 0.013, 243, 77, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1038, 1g0uF, 0.5047, 3.67, 0.013, 243, 76, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1039, 6hw3T, 0.5046, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 13 
1040, 6hw3F, 0.5046, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 13 
1041, 6hvuM, 0.5046, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 29 
1042, 6hv7T, 0.5046, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 7 
1043, 6htpT, 0.5046, 4.11, 0.087, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 7 
1044, 6g8mT, 0.5046, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH CYSTARGOLIDE B DERIVATIVE 1 
1045, 6fvuG, 0.5046, 3.68, 0.013, 243, 76, struct.pdbx_descriptor              
1046, 5vfqN, 0.5046, 3.68, 0.013, 243, 76, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1047, 5vfqMA, 0.5046, 4.13, 0.075, 233, 80, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1048, 5l67Z, 0.5046, 4.38, 0.122, 216, 82, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1049, 5l55a, 0.5046, 3.72, 0.013, 242, 76, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1050, 5l55T, 0.5046, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1051, 5l55M, 0.5046, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1052, 5l55F, 0.5046, 4.15, 0.086, 233, 81, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1053, 5dkiZ, 0.5046, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1054, 5dkiL, 0.5046, 3.67, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1055, 5d0vT, 0.5046, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1056, 5d0vF, 0.5046, 3.66, 0.013, 242, 75, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1057, 5d0sT, 0.5046, 4.25, 0.123, 215, 81, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1058, 5czaF, 0.5046, 4.34, 0.122, 215, 82, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1059, 5cz8T, 0.5046, 3.62, 0.054, 222, 74, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1060, 5bxlT, 0.5046, 4.01, 0.089, 229, 79, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1061, 4y8iT, 0.5046, 3.67, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1062, 4qwgZ, 0.5046, 4.01, 0.089, 228, 79, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1063, 4qvlF, 0.5046, 3.67, 0.013, 243, 76, YCP IN COMPLEX WITH BORTEZOMIB
1064, 4qltM, 0.5046, 4.15, 0.063, 222, 79, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1065, 4qlqT, 0.5046, 4.15, 0.063, 222, 79, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1066, 4qlqF, 0.5046, 3.68, 0.013, 243, 76, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1067, 4q1sL, 0.5046, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1068, 4no9F, 0.5046, 3.68, 0.013, 243, 76, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1069, 3sdiT, 0.5046, 3.67, 0.013, 243, 76, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1070, 3oeuZ, 0.5046, 3.68, 0.013, 243, 76, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1071, 6hw3a, 0.5045, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 13 
1072, 6hw3M, 0.5045, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 13 
1073, 6hv5T, 0.5045, 3.83, 0.079, 222, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 4 
1074, 6htpF, 0.5045, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 7 
1075, 6g8mF, 0.5045, 4.11, 0.087, 233, 80, YEAST 20S PROTEASOME IN COMPLEX WITH CYSTARGOLIDE B DERIVATIVE 1 
1076, 6fvwU, 0.5045, 3.69, 0.013, 243, 76, struct.pdbx_descriptor              
1077, 5l6aT, 0.5045, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1078, 5l5sT, 0.5045, 3.93, 0.065, 222, 77, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1079, 5l5hT, 0.5045, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1080, 5l5hF, 0.5045, 3.91, 0.013, 242, 78, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1081, 5l5bT, 0.5045, 4.13, 0.063, 222, 79, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1082, 5l5bF, 0.5045, 4.12, 0.087, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1083, 5d0sF, 0.5045, 4.12, 0.087, 233, 80, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1084, 5cggF, 0.5045, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1085, 5cgfM, 0.5045, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1086, 5bxlF, 0.5045, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1087, 5a0qb, 0.5045, 3.69, 0.013, 245, 76, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
1088, 5a0qN, 0.5045, 3.68, 0.013, 243, 76, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
1089, 4r02F, 0.5045, 3.68, 0.013, 243, 76, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1090, 4qz6T, 0.5045, 3.68, 0.013, 243, 76, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1091, 4qz6F, 0.5045, 3.68, 0.013, 243, 76, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1092, 4qz5T, 0.5045, 3.67, 0.013, 243, 76, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1093, 4qz3F, 0.5045, 3.67, 0.013, 243, 76, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1094, 4qvwM, 0.5045, 3.68, 0.013, 243, 76, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1095, 4qvla, 0.5045, 3.68, 0.013, 243, 76, YCP IN COMPLEX WITH BORTEZOMIB
1096, 4qvlT, 0.5045, 4.16, 0.086, 233, 81, YCP IN COMPLEX WITH BORTEZOMIB
1097, 4qvlM, 0.5045, 3.68, 0.013, 243, 76, YCP IN COMPLEX WITH BORTEZOMIB
1098, 4no8T, 0.5045, 3.20, 0.139, 184, 72, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1099, 4no8F, 0.5045, 3.20, 0.139, 184, 72, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1100, 3wxr2, 0.5045, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1101, 2gplF, 0.5045, 3.69, 0.013, 243, 76, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1102, 2fakT, 0.5045, 3.69, 0.013, 243, 76, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1103, 6hvaT, 0.5044, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 13 
1104, 6hv5F, 0.5044, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 4 
1105, 6huba, 0.5044, 4.14, 0.087, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 16 
1106, 6htba, 0.5044, 4.16, 0.086, 233, 81, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) 
1107, 6htbT, 0.5044, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) 
1108, 5mp9A, 0.5044, 4.16, 0.086, 233, 81, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1109, 5lttT, 0.5044, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1110, 5l6aF, 0.5044, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1111, 5l69M, 0.5044, 4.16, 0.086, 233, 81, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1112, 5l60Z, 0.5044, 3.68, 0.013, 244, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1113, 5l5wT, 0.5044, 3.68, 0.013, 244, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1114, 5l5wF, 0.5044, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1115, 5l5sF, 0.5044, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1116, 5cgfa, 0.5044, 4.15, 0.086, 224, 81, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1117, 4y8sT, 0.5044, 4.02, 0.076, 224, 79, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1118, 4y8sF, 0.5044, 3.67, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1119, 4y8jT, 0.5044, 3.44, 0.079, 241, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1120, 4y8jF, 0.5044, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1121, 4y8iF, 0.5044, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1122, 4y75T, 0.5044, 4.12, 0.087, 233, 80, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1123, 4y75F, 0.5044, 3.89, 0.078, 222, 77, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1124, 4qz4F, 0.5044, 3.68, 0.013, 243, 76, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1125, 4qz3T, 0.5044, 3.68, 0.013, 243, 76, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1126, 4qw4T, 0.5044, 3.68, 0.013, 243, 76, YCP IN COMPLEX WITH CARFILZOMIB
1127, 4qw4F, 0.5044, 4.16, 0.086, 233, 81, YCP IN COMPLEX WITH CARFILZOMIB
1128, 4qvpT, 0.5044, 3.70, 0.013, 243, 76, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1129, 4qvpF, 0.5044, 3.70, 0.013, 243, 76, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1130, 4lqiM, 0.5044, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1131, 3un8M, 0.5044, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1132, 3shjT, 0.5044, 3.69, 0.013, 243, 76, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1133, 3gpwT, 0.5044, 3.68, 0.013, 243, 76, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1134, 1jd2F, 0.5044, 3.68, 0.013, 243, 76, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1135, 6hwcT, 0.5043, 3.67, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-G45A MUTANT 
1136, 6hw7F, 0.5043, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 29 
1137, 6hvtM, 0.5043, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 20 
1138, 6hvrL, 0.5043, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 16 
1139, 6hvaF, 0.5043, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 13 
1140, 6hv3T, 0.5043, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) 
1141, 6huvZ, 0.5043, 4.05, 0.075, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 39 
1142, 6huvL, 0.5043, 4.23, 0.086, 233, 81, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 39 
1143, 6huvF, 0.5043, 3.66, 0.013, 244, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 39 
1144, 6hubF, 0.5043, 3.67, 0.013, 244, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 16 
1145, 6g7fT, 0.5043, 3.82, 0.026, 244, 77, YEAST 20S PROTEASOME IN COMPLEX WITH CYSTARGOLIDE B 
1146, 5lttF, 0.5043, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1147, 5l69a, 0.5043, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1148, 5l69T, 0.5043, 4.02, 0.076, 233, 79, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1149, 5l5xL, 0.5043, 4.12, 0.063, 222, 79, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1150, 5l54T, 0.5043, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1151, 5l54F, 0.5043, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1152, 5fg9T, 0.5043, 4.12, 0.063, 222, 79, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1153, 5cggT, 0.5043, 4.12, 0.063, 222, 79, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1154, 5ahjT, 0.5043, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1155, 5ahjF, 0.5043, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1156, 4y8tT, 0.5043, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1157, 4y8tF, 0.5043, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1158, 4y8lT, 0.5043, 4.12, 0.087, 233, 80, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1159, 4y77T, 0.5043, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1160, 4y77F, 0.5043, 3.88, 0.078, 222, 77, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1161, 4y6vZ, 0.5043, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1162, 4v7oOA, 0.5043, 3.69, 0.013, 243, 76, 
1163, 4qz4T, 0.5043, 3.80, 0.013, 243, 77, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1164, 4qw1T, 0.5043, 3.70, 0.013, 243, 76, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1165, 4qv1M, 0.5043, 3.68, 0.013, 243, 76, YCP BETA5-M45A MUTANT
1166, 4lqia, 0.5043, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1167, 4inrT, 0.5043, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1168, 4eu2U, 0.5043, 3.70, 0.013, 243, 76, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1169, 4eu22, 0.5043, 3.69, 0.013, 243, 76, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1170, 2zcyT, 0.5043, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1171, 2w03A, 0.5043, 3.68, 0.013, 243, 76, CO-COMPLEX STRUCTURE OF ACHROMOBACTIN SYNTHETASE PROTEIN D ( ACSD) WITH ADENOSINE SULFATE AND CITRATE FROM PECTOBACTERIUM CHRYSANTHEMI
1172, 1rypN, 0.5043, 3.84, 0.066, 222, 76, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1173, 1g651, 0.5043, 3.68, 0.013, 244, 76, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1174, 6hwdF, 0.5042, 3.67, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH BORTEZOMIB 
1175, 6hwcF, 0.5042, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-G45A MUTANT 
1176, 6hw7T, 0.5042, 4.16, 0.086, 233, 81, YEAST 20S PROTEASOME IN COMPLEX WITH 29 
1177, 6hvrZ, 0.5042, 4.05, 0.075, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 16 
1178, 6hvaZ, 0.5042, 3.69, 0.013, 244, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 13 
1179, 6hvaL, 0.5042, 3.80, 0.013, 244, 77, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 13 
1180, 6hv3F, 0.5042, 4.01, 0.114, 233, 79, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) 
1181, 6huvT, 0.5042, 3.68, 0.013, 244, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 39 
1182, 6htrF, 0.5042, 4.01, 0.024, 574, 82, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 13 
1183, 6htbM, 0.5042, 4.15, 0.074, 233, 81, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) 
1184, 6htbF, 0.5042, 4.15, 0.074, 233, 81, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) 
1185, 5vfpLA, 0.5042, 3.69, 0.013, 243, 76, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1186, 5m32M, 0.5042, 3.68, 0.013, 243, 76, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
1187, 5l69F, 0.5042, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1188, 5l63T, 0.5042, 4.12, 0.063, 222, 79, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1189, 5l63F, 0.5042, 4.12, 0.063, 222, 79, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1190, 5l5xZ, 0.5042, 4.12, 0.063, 222, 79, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1191, 5l52T, 0.5042, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1192, 5l52F, 0.5042, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1193, 5fg9F, 0.5042, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1194, 5cz9T, 0.5042, 4.01, 0.076, 224, 79, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1195, 4zzgN, 0.5042, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1196, 4z1lM, 0.5042, 4.24, 0.123, 215, 81, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1197, 4ya1T, 0.5042, 4.35, 0.122, 216, 82, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1198, 4ya1F, 0.5042, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1199, 4y8lF, 0.5042, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1200, 4y84T, 0.5042, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1201, 4y74F, 0.5042, 3.88, 0.078, 222, 77, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1202, 4y70T, 0.5042, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1203, 4y70F, 0.5042, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1204, 4v7oG, 0.5042, 3.80, 0.013, 243, 77, 
1205, 4qw7T, 0.5042, 3.69, 0.013, 243, 76, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1206, 4qvnF, 0.5042, 4.04, 0.076, 232, 79, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1207, 4qv1a, 0.5042, 4.13, 0.087, 229, 80, YCP BETA5-M45A MUTANT
1208, 4nnwL, 0.5042, 3.80, 0.013, 243, 77, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1209, 3shjF, 0.5042, 3.80, 0.013, 243, 77, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1210, 3d29M, 0.5042, 3.69, 0.013, 243, 76, PROTEASOME INHIBITION BY FELLUTAMIDE B
1211, 2fakF, 0.5042, 3.69, 0.013, 243, 76, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1212, 6hwdT, 0.5041, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH BORTEZOMIB 
1213, 6hvyL, 0.5041, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 5 (7- AND 6-MEMBERED RING) 
1214, 6htrT, 0.5041, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 13 
1215, 6g8nT, 0.5041, 3.68, 0.013, 244, 76, YEAST 20S PROTEASOME IN COMPLEX WITH CYSTARGOLIDE B DERIVATIVE 2 
1216, 6fvtG, 0.5041, 3.69, 0.013, 243, 76, struct.pdbx_descriptor              
1217, 5l6ba, 0.5041, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1218, 5l62T, 0.5041, 4.16, 0.086, 233, 81, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1219, 5l62F, 0.5041, 3.75, 0.093, 222, 75, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1220, 5l5zT, 0.5041, 3.66, 0.013, 244, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1221, 5l5pT, 0.5041, 4.14, 0.087, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1222, 5l5pF, 0.5041, 3.68, 0.013, 244, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1223, 5l5aT, 0.5041, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1224, 5l5aF, 0.5041, 3.76, 0.067, 222, 75, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1225, 5jhsT, 0.5041, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1226, 5fgfF, 0.5041, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1227, 5dkjT, 0.5041, 3.83, 0.026, 245, 76, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1228, 5dkjF, 0.5041, 4.13, 0.087, 233, 80, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1229, 5czaa, 0.5041, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1230, 5cz9F, 0.5041, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1231, 5bouM, 0.5041, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1232, 4z1lT, 0.5041, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1233, 4y80T, 0.5041, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1234, 4y80F, 0.5041, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1235, 4y7yT, 0.5041, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1236, 4y74T, 0.5041, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1237, 4qzzF, 0.5041, 3.69, 0.013, 243, 76, YCP IN COMPLEX WITH OMURALIDE
1238, 4qzwT, 0.5041, 3.69, 0.013, 243, 76, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1239, 4qzwF, 0.5041, 3.69, 0.013, 243, 76, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1240, 4qw6F, 0.5041, 4.01, 0.089, 232, 79, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1241, 4qw1a, 0.5041, 3.69, 0.013, 243, 76, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1242, 4qw1M, 0.5041, 4.13, 0.087, 229, 80, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1243, 4qw1F, 0.5041, 3.68, 0.013, 243, 76, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1244, 4qvnT, 0.5041, 3.69, 0.013, 243, 76, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1245, 4jt0T, 0.5041, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1246, 3gpwF, 0.5041, 3.70, 0.013, 243, 76, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1247, 2zcyF, 0.5041, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1248, 2fakM, 0.5041, 3.68, 0.013, 243, 76, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1249, 2fak1, 0.5041, 3.69, 0.013, 243, 76, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1250, 1rypO, 0.5041, 3.69, 0.013, 243, 76, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1251, 6hwbF, 0.5040, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 44B 
1252, 6hvwT, 0.5040, 4.16, 0.086, 233, 81, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 43 
1253, 6fvuO, 0.5040, 4.16, 0.086, 233, 81, struct.pdbx_descriptor              
1254, 5l64T, 0.5040, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1255, 5l64F, 0.5040, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1256, 5l60T, 0.5040, 3.68, 0.013, 244, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1257, 5l60F, 0.5040, 3.68, 0.013, 244, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1258, 5l5zF, 0.5040, 3.68, 0.013, 244, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1259, 5l5hM, 0.5040, 4.03, 0.089, 233, 79, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1260, 5jhsF, 0.5040, 4.03, 0.089, 233, 79, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1261, 5fgfT, 0.5040, 3.59, 0.039, 243, 77, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1262, 5czaM, 0.5040, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1263, 5cz6T, 0.5040, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1264, 4z1la, 0.5040, 3.50, 0.079, 242, 76, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1265, 4z1lF, 0.5040, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1266, 4y9ya, 0.5040, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1267, 4y9yT, 0.5040, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1268, 4y9yF, 0.5040, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1269, 4y7yF, 0.5040, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1270, 4y7wT, 0.5040, 4.13, 0.087, 233, 80, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1271, 4y7wF, 0.5040, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1272, 4r18T, 0.5040, 3.69, 0.013, 243, 76, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1273, 4r18F, 0.5040, 4.02, 0.089, 229, 79, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1274, 4qzzT, 0.5040, 3.68, 0.013, 243, 76, YCP IN COMPLEX WITH OMURALIDE
1275, 4qwrL, 0.5040, 4.02, 0.076, 232, 79, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1276, 4qw6T, 0.5040, 3.69, 0.013, 243, 76, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1277, 4qw5T, 0.5040, 4.16, 0.086, 233, 81, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1278, 4qw5F, 0.5040, 3.68, 0.013, 243, 76, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1279, 4qvmF, 0.5040, 3.68, 0.013, 243, 76, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1280, 4qv8T, 0.5040, 3.70, 0.013, 243, 76, YCP BETA5-C52F MUTANT
1281, 4qv8F, 0.5040, 3.69, 0.013, 243, 76, YCP BETA5-C52F MUTANT
1282, 4qv7a, 0.5040, 3.68, 0.013, 243, 76, YCP BETA5-A50V MUTANT
1283, 4qv7T, 0.5040, 3.68, 0.013, 243, 76, YCP BETA5-A50V MUTANT
1284, 4qv1T, 0.5040, 3.68, 0.013, 243, 76, YCP BETA5-M45A MUTANT
1285, 4jt0F, 0.5040, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1286, 3d29L, 0.5040, 3.83, 0.079, 222, 76, PROTEASOME INHIBITION BY FELLUTAMIDE B
1287, 1jd2G, 0.5040, 3.69, 0.013, 243, 76, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1288, 6hw4F, 0.5039, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 16 
1289, 6hw0T, 0.5039, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 7 
1290, 6hvyT, 0.5039, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 5 (7- AND 6-MEMBERED RING) 
1291, 6hvyF, 0.5039, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 5 (7- AND 6-MEMBERED RING) 
1292, 6htra, 0.5039, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 13 
1293, 6g8ma, 0.5039, 4.16, 0.086, 233, 81, YEAST 20S PROTEASOME IN COMPLEX WITH CYSTARGOLIDE B DERIVATIVE 1 
1294, 5vfoT, 0.5039, 3.68, 0.013, 243, 76, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1295, 5mpbU, 0.5039, 3.68, 0.013, 243, 76, 
1296, 5mp9m, 0.5039, 3.68, 0.013, 244, 76, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1297, 5l6bT, 0.5039, 4.03, 0.063, 222, 79, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1298, 5l6bF, 0.5039, 3.46, 0.079, 243, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1299, 5l67F, 0.5039, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1300, 5l61T, 0.5039, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1301, 5l61F, 0.5039, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1302, 5l5xT, 0.5039, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1303, 5l5xF, 0.5039, 4.14, 0.087, 228, 80, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1304, 5dkiT, 0.5039, 4.14, 0.087, 232, 80, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1305, 5dkiF, 0.5039, 4.24, 0.123, 215, 81, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1306, 5cz6F, 0.5039, 3.92, 0.039, 243, 77, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1307, 5bouF, 0.5039, 3.76, 0.054, 222, 74, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1308, 4zzgU, 0.5039, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1309, 4y9yM, 0.5039, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1310, 4qwrT, 0.5039, 3.69, 0.013, 243, 76, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1311, 4qw7F, 0.5039, 3.69, 0.013, 243, 76, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1312, 4qvyT, 0.5039, 3.69, 0.013, 243, 76, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1313, 4qvyF, 0.5039, 3.69, 0.013, 243, 76, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1314, 4qvwT, 0.5039, 3.69, 0.013, 243, 76, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1315, 4qvwF, 0.5039, 3.70, 0.013, 243, 76, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1316, 4qvmT, 0.5039, 3.70, 0.013, 243, 76, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1317, 4ltcT, 0.5039, 3.68, 0.013, 243, 76, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1318, 4jsqM, 0.5039, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1319, 3wxr1, 0.5039, 3.68, 0.013, 244, 76, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1320, 3tdd1, 0.5039, 4.16, 0.086, 233, 81, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1321, 3okjT, 0.5039, 3.69, 0.013, 243, 76, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1322, 3nzx1, 0.5039, 3.71, 0.013, 243, 76, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1323, 6hwbT, 0.5038, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 44B 
1324, 6hw0F, 0.5038, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 7 
1325, 6hvxT, 0.5038, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 4 
1326, 6hvxF, 0.5038, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 4 
1327, 6hvwF, 0.5038, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 43 
1328, 6htrL, 0.5038, 3.68, 0.013, 244, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 13 
1329, 6htcF, 0.5038, 4.23, 0.086, 233, 81, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH ONX 0914 
1330, 6g8nF, 0.5038, 3.87, 0.065, 222, 77, YEAST 20S PROTEASOME IN COMPLEX WITH CYSTARGOLIDE B DERIVATIVE 2 
1331, 5nifU, 0.5038, 4.03, 0.089, 233, 79, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1332, 5mpaa, 0.5038, 3.67, 0.013, 244, 76, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1333, 5m2bT, 0.5038, 4.12, 0.087, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1334, 5m2bF, 0.5038, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1335, 5lajT, 0.5038, 3.69, 0.013, 243, 76, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1336, 5lajF, 0.5038, 3.69, 0.013, 243, 76, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1337, 5l6aa, 0.5038, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1338, 5l67T, 0.5038, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1339, 5l66T, 0.5038, 3.79, 0.066, 222, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1340, 5l66F, 0.5038, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1341, 5l5zZ, 0.5038, 3.71, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1342, 5l5zL, 0.5038, 3.66, 0.013, 244, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1343, 5l5yT, 0.5038, 3.44, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1344, 5l5yF, 0.5038, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1345, 5l5uL, 0.5038, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1346, 5l5oM, 0.5038, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1347, 5l5ia, 0.5038, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1348, 5l5iT, 0.5038, 4.17, 0.086, 233, 81, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1349, 5l5iM, 0.5038, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1350, 5l5iF, 0.5038, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1351, 5l5dT, 0.5038, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1352, 5l5dF, 0.5038, 3.89, 0.065, 222, 77, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1353, 5d0zT, 0.5038, 3.89, 0.065, 222, 77, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1354, 5d0zF, 0.5038, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1355, 5d0tT, 0.5038, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1356, 5d0tF, 0.5038, 4.12, 0.063, 222, 79, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1357, 5bouT, 0.5038, 4.14, 0.087, 233, 80, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1358, 4zzgG, 0.5038, 4.14, 0.075, 233, 80, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1359, 4y8oT, 0.5038, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1360, 4y8oF, 0.5038, 4.14, 0.075, 233, 80, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1361, 4y69T, 0.5038, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1362, 4u39G, 0.5038, 3.68, 0.013, 243, 76, CRYSTAL STRUCTURE OF FTSZ:MCIZ COMPLEX FROM BACILLUS SUBTILIS
1363, 4qwrF, 0.5038, 3.68, 0.013, 243, 76, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1364, 4qwkZ, 0.5038, 3.69, 0.013, 243, 76, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1365, 4qwkL, 0.5038, 3.69, 0.013, 243, 76, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1366, 4qwiT, 0.5038, 3.70, 0.013, 243, 76, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1367, 4qwiF, 0.5038, 3.70, 0.013, 243, 76, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1368, 4qv7M, 0.5038, 3.69, 0.013, 243, 76, YCP BETA5-A50V MUTANT
1369, 4qv1F, 0.5038, 3.96, 0.025, 244, 79, YCP BETA5-M45A MUTANT
1370, 4qv0T, 0.5038, 3.69, 0.013, 243, 76, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1371, 4qbya, 0.5038, 3.69, 0.013, 243, 76, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1372, 4qbyT, 0.5038, 3.70, 0.013, 243, 76, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1373, 4qbyM, 0.5038, 3.81, 0.049, 279, 81, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1374, 4jsqa, 0.5038, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1375, 4g4sG, 0.5038, 3.87, 0.092, 222, 76, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
1376, 3un8F, 0.5038, 3.87, 0.092, 222, 76, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1377, 3un4M, 0.5038, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1378, 3tddM, 0.5038, 3.69, 0.013, 243, 76, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1379, 3okjF, 0.5038, 4.02, 0.089, 233, 79, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1380, 3nzxT, 0.5038, 3.69, 0.013, 243, 76, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1381, 6j30V, 0.5037, 3.69, 0.013, 243, 76, struct.pdbx_descriptor              
1382, 6hw4T, 0.5037, 4.12, 0.087, 233, 80, YEAST 20S PROTEASOME IN COMPLEX WITH 16 
1383, 6g7fM, 0.5037, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH CYSTARGOLIDE B 
1384, 5l6cT, 0.5037, 4.12, 0.087, 233, 80, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1385, 5l6cF, 0.5037, 4.23, 0.086, 233, 81, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1386, 5l68F, 0.5037, 3.69, 0.013, 246, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1387, 5l65T, 0.5037, 3.69, 0.013, 244, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1388, 5l65F, 0.5037, 4.04, 0.075, 233, 80, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1389, 5l5ua, 0.5037, 4.02, 0.089, 233, 79, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1390, 5l5qT, 0.5037, 3.67, 0.013, 244, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1391, 5fhsT, 0.5037, 3.68, 0.013, 244, 76, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1392, 5fhsF, 0.5037, 3.43, 0.079, 241, 76, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1393, 5d0xF, 0.5037, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1394, 5cz7T, 0.5037, 4.05, 0.087, 229, 80, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1395, 5cghT, 0.5037, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1396, 5cghF, 0.5037, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1397, 5boua, 0.5037, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1398, 4y9zM, 0.5037, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1399, 4y8uT, 0.5037, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1400, 4y8sL, 0.5037, 4.06, 0.075, 233, 80, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1401, 4y69F, 0.5037, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1402, 4qwxT, 0.5037, 3.70, 0.013, 243, 76, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1403, 4qwxF, 0.5037, 3.70, 0.013, 243, 76, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1404, 4qwfF, 0.5037, 3.70, 0.013, 243, 76, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1405, 4qvqT, 0.5037, 3.69, 0.013, 243, 76, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1406, 4qvqF, 0.5037, 3.69, 0.013, 243, 76, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1407, 4qv0F, 0.5037, 3.69, 0.013, 243, 76, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1408, 4qbyF, 0.5037, 4.13, 0.087, 232, 80, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1409, 4no6F, 0.5037, 4.12, 0.087, 233, 80, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1410, 4no1T, 0.5037, 3.70, 0.013, 243, 76, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1411, 4no1F, 0.5037, 4.12, 0.063, 222, 79, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1412, 4fzcT, 0.5037, 3.70, 0.013, 243, 76, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1413, 3un8T, 0.5037, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1414, 3d29Z, 0.5037, 3.69, 0.013, 243, 76, PROTEASOME INHIBITION BY FELLUTAMIDE B
1415, 3bdmT, 0.5037, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1416, 6hweT, 0.5036, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH CARFILZOMIB 
1417, 6hweF, 0.5036, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH CARFILZOMIB 
1418, 6htcT, 0.5036, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH ONX 0914 
1419, 5m32a, 0.5036, 3.68, 0.013, 243, 76, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
1420, 5l5tM, 0.5036, 3.68, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1421, 5l5qF, 0.5036, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1422, 5l5pa, 0.5036, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1423, 5l5jT, 0.5036, 3.69, 0.013, 244, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1424, 5l5jF, 0.5036, 3.56, 0.013, 244, 75, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1425, 5cz7F, 0.5036, 4.03, 0.063, 222, 79, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1426, 4y8sZ, 0.5036, 3.69, 0.013, 244, 76, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1427, 4y8mT, 0.5036, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1428, 4y78T, 0.5036, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1429, 4y78F, 0.5036, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1430, 4x6z1, 0.5036, 4.37, 0.122, 216, 82, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1431, 4r02T, 0.5036, 4.13, 0.087, 233, 80, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1432, 4qv5T, 0.5036, 3.69, 0.013, 243, 76, YCP BETA5-M45I MUTANT
1433, 4qv4T, 0.5036, 4.14, 0.087, 233, 80, YCP BETA5-M45T MUTANT
1434, 4qv4F, 0.5036, 3.69, 0.013, 243, 76, YCP BETA5-M45T MUTANT
1435, 4qlua, 0.5036, 3.70, 0.013, 243, 76, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1436, 4qluM, 0.5036, 3.71, 0.013, 243, 76, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1437, 4hnpT, 0.5036, 4.12, 0.063, 222, 79, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1438, 4gk7T, 0.5036, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1439, 4fzcF, 0.5036, 3.70, 0.013, 243, 76, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1440, 3okjM, 0.5036, 3.70, 0.013, 243, 76, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1441, 3nzxM, 0.5036, 3.87, 0.065, 222, 77, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1442, 3mg0T, 0.5036, 3.68, 0.013, 243, 76, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1443, 6j2cM, 0.5035, 3.69, 0.013, 243, 76, struct.pdbx_descriptor              
1444, 6hw6T, 0.5035, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 20 
1445, 6h39F, 0.5035, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC NON-COVALENT BINDING INHIBITOR RTS-V5 
1446, 6g8mM, 0.5035, 4.03, 0.089, 233, 79, YEAST 20S PROTEASOME IN COMPLEX WITH CYSTARGOLIDE B DERIVATIVE 1 
1447, 6fvtU, 0.5035, 4.03, 0.089, 233, 79, struct.pdbx_descriptor              
1448, 5l68T, 0.5035, 3.80, 0.013, 244, 77, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1449, 5l5zM, 0.5035, 3.67, 0.013, 244, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1450, 5l5ta, 0.5035, 3.69, 0.013, 244, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1451, 5l5tT, 0.5035, 4.03, 0.089, 233, 79, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1452, 5l5tF, 0.5035, 4.03, 0.089, 233, 79, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1453, 5l5oT, 0.5035, 3.68, 0.013, 244, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1454, 5l5eT, 0.5035, 3.83, 0.053, 222, 75, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1455, 5fgiT, 0.5035, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1456, 5fgiF, 0.5035, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1457, 5fgeT, 0.5035, 4.13, 0.087, 229, 80, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1458, 5fgeF, 0.5035, 3.79, 0.013, 245, 76, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1459, 5d0xT, 0.5035, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1460, 5cz5T, 0.5035, 4.24, 0.086, 233, 81, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1461, 5cz5F, 0.5035, 4.13, 0.087, 233, 80, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1462, 5cgiT, 0.5035, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1463, 5cgiF, 0.5035, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1464, 4ya1a, 0.5035, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1465, 4ya1M, 0.5035, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1466, 4y8mF, 0.5035, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1467, 4y82T, 0.5035, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1468, 4y7xT, 0.5035, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1469, 4y7xF, 0.5035, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1470, 4rurT, 0.5035, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1471, 4qzxT, 0.5035, 3.70, 0.013, 243, 76, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1472, 4qzxF, 0.5035, 3.70, 0.013, 243, 76, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1473, 4qz7T, 0.5035, 3.69, 0.013, 243, 76, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1474, 4qz7F, 0.5035, 3.69, 0.013, 243, 76, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1475, 4qz3M, 0.5035, 4.17, 0.086, 233, 81, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1476, 4qwxa, 0.5035, 4.17, 0.086, 233, 81, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1477, 4qwla, 0.5035, 3.69, 0.013, 243, 76, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1478, 4qwlM, 0.5035, 3.70, 0.013, 243, 76, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1479, 4qwfT, 0.5035, 3.70, 0.013, 243, 76, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1480, 4qv5F, 0.5035, 3.70, 0.013, 243, 76, YCP BETA5-M45I MUTANT
1481, 4jsqF, 0.5035, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1482, 4inrF, 0.5035, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1483, 4eu2G, 0.5035, 3.70, 0.013, 243, 76, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1484, 3bdmF, 0.5035, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1485, 6hw6F, 0.5034, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 20 
1486, 6hw5L, 0.5034, 4.13, 0.087, 233, 80, YEAST 20S PROTEASOME IN COMPLEX WITH 18 
1487, 6h39T, 0.5034, 4.14, 0.087, 233, 80, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC NON-COVALENT BINDING INHIBITOR RTS-V5 
1488, 5laiT, 0.5034, 4.16, 0.086, 233, 81, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1489, 5l5vT, 0.5034, 4.16, 0.086, 233, 81,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1490, 5l5vF, 0.5034, 3.70, 0.013, 243, 76,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1491, 5l5oF, 0.5034, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1492, 5l5eF, 0.5034, 3.69, 0.013, 244, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1493, 5fgdF, 0.5034, 3.69, 0.013, 244, 76, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1494, 4y8qT, 0.5034, 3.68, 0.013, 244, 76, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1495, 4y8qF, 0.5034, 3.69, 0.013, 244, 76, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1496, 4y8kT, 0.5034, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1497, 4y8kF, 0.5034, 3.81, 0.079, 222, 76, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1498, 4y82F, 0.5034, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1499, 4y6aT, 0.5034, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1500, 4y6aF, 0.5034, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1501, 4rurF, 0.5034, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1502, 4qz2T, 0.5034, 3.69, 0.013, 243, 76, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1503, 4qz2F, 0.5034, 3.69, 0.013, 243, 76, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1504, 4qz0T, 0.5034, 3.71, 0.013, 243, 76, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1505, 4qz0F, 0.5034, 3.70, 0.013, 243, 76, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1506, 4qwxM, 0.5034, 3.70, 0.013, 243, 76, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1507, 4qw0T, 0.5034, 3.70, 0.013, 243, 76, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1508, 4qw0F, 0.5034, 3.70, 0.013, 243, 76, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1509, 4nnna, 0.5034, 3.70, 0.013, 243, 76, YCP IN COMPLEX WITH MG132
1510, 4jsqT, 0.5034, 3.71, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1511, 4hrdT, 0.5034, 3.71, 0.013, 243, 76, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1512, 3oev1, 0.5034, 3.69, 0.013, 243, 76, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1513, 6hw8T, 0.5033, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 39 
1514, 6htrZ, 0.5033, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 13 
1515, 5laiF, 0.5033, 3.69, 0.013, 243, 76, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1516, 5l6aZ, 0.5033, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1517, 5l5ja, 0.5033, 4.14, 0.087, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1518, 5l5jM, 0.5033, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1519, 5l5ba, 0.5033, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1520, 5fghT, 0.5033, 4.15, 0.086, 233, 81, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1521, 5fghF, 0.5033, 3.71, 0.013, 244, 76, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1522, 5fgdT, 0.5033, 3.69, 0.013, 244, 76, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1523, 4y8uF, 0.5033, 4.27, 0.073, 233, 82, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1524, 4y8nF, 0.5033, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1525, 4y6vF, 0.5033, 3.78, 0.066, 222, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1526, 4qz1T, 0.5033, 3.70, 0.013, 243, 76, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1527, 4qz1F, 0.5033, 3.82, 0.079, 222, 76, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1528, 4qvwa, 0.5033, 4.14, 0.087, 233, 80, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1529, 4qv3T, 0.5033, 4.14, 0.087, 233, 80, YCP BETA5-M45V MUTANT
1530, 4quxT, 0.5033, 4.06, 0.075, 233, 80, YCP BETA5-A49T-MUTANT
1531, 4quxF, 0.5033, 3.70, 0.013, 243, 76, YCP BETA5-A49T-MUTANT
1532, 4nnnM, 0.5033, 3.70, 0.013, 243, 76, YCP IN COMPLEX WITH MG132
1533, 4ltcF, 0.5033, 3.71, 0.013, 243, 76, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1534, 4intM, 0.5033, 3.73, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1535, 4fzca, 0.5033, 3.70, 0.013, 243, 76, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1536, 4fzcM, 0.5033, 3.70, 0.013, 243, 76, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1537, 3mg8L, 0.5033, 3.70, 0.013, 243, 76, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1538, 3jvhA, 0.5033, 3.70, 0.013, 243, 76, CRYSTAL STRUCTURE OF 2C-METHYL-D-ERYTHRITOL-24-CYCLODIPHOSPHATE SYNTHASE FROM BURKHOLDERIA PSEUDOMALLEI WITH FOL FRAGMENT 8395
1539, 3iewA, 0.5033, 4.03, 0.089, 233, 79, CRYSTAL STRUCTURE OF 2C-METHYL-D-ERYTHRITOL 24-CYCLODIPHOSPHATE SYNTHASE FROM BURKHOLDERIA PSEUDOMALLEI WITH BOUND CTP AND CDP
1540, 6hwaT, 0.5032, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 43 
1541, 6hw9F, 0.5032, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 41B 
1542, 6hw8F, 0.5032, 3.69, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 39 
1543, 5l6ca, 0.5032, 4.15, 0.086, 233, 81, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1544, 5l5bM, 0.5032, 3.68, 0.013, 244, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1545, 5l52a, 0.5032, 4.02, 0.114, 233, 79, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1546, 5l52M, 0.5032, 4.03, 0.076, 233, 79, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1547, 5ey0A, 0.5032, 4.03, 0.076, 233, 79, CRYSTAL STRUCTURE OF CODY FROM STAPHYLOCOCCUS AUREUS WITH GTP AND ILE
1548, 4y8nT, 0.5032, 4.01, 0.064, 222, 78, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1549, 4y81T, 0.5032, 4.09, 0.114, 158, 79, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1550, 4y81F, 0.5032, 4.08, 0.114, 160, 79, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1551, 4y6zT, 0.5032, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1552, 4y6zF, 0.5032, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1553, 4y6va, 0.5032, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1554, 4y6vT, 0.5032, 4.14, 0.087, 233, 80, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1555, 4qv8a, 0.5032, 4.06, 0.075, 233, 80, YCP BETA5-C52F MUTANT
1556, 4qv3F, 0.5032, 4.03, 0.089, 225, 79, YCP BETA5-M45V MUTANT
1557, 4inta, 0.5032, 4.03, 0.089, 225, 79, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1558, 3unb3, 0.5032, 3.75, 0.026, 252, 78, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1559, 6j2nV, 0.5031, 3.70, 0.013, 243, 76, struct.pdbx_descriptor              
1560, 6hwaF, 0.5031, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 43 
1561, 6hw9T, 0.5031, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 41B 
1562, 6hvvM, 0.5031, 3.71, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 39 
1563, 5vfrT, 0.5031, 3.71, 0.013, 243, 76, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1564, 5d0za, 0.5031, 4.14, 0.087, 233, 80, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1565, 5d0zM, 0.5031, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1566, 4y6vM, 0.5031, 4.03, 0.089, 233, 79, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1567, 4qzza, 0.5031, 3.69, 0.013, 243, 76, YCP IN COMPLEX WITH OMURALIDE
1568, 4qz0a, 0.5031, 4.03, 0.114, 233, 79, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1569, 4qwjT, 0.5031, 4.40, 0.122, 216, 82, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1570, 4qwjF, 0.5031, 3.46, 0.066, 241, 76, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1571, 4qvvT, 0.5031, 3.70, 0.013, 243, 76, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1572, 4qvvF, 0.5031, 3.70, 0.013, 243, 76, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1573, 4qv4M, 0.5031, 4.02, 0.089, 233, 79, YCP BETA5-M45T MUTANT
1574, 4hrdF, 0.5031, 4.38, 0.122, 215, 82, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1575, 3hyeM, 0.5031, 4.03, 0.089, 233, 79, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1576, 3bdmL, 0.5031, 4.03, 0.076, 233, 79, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1577, 2w04A, 0.5031, 4.14, 0.087, 233, 80, CO-COMPLEX STRUCTURE OF ACHROMOBACTIN SYNTHETASE PROTEIN D ( ACSD) WITH CITRATE IN ATP BINDING SITE FROM PECTOBACTERIUM CHRYSANTHEMI
1578, 6hvva, 0.5030, 4.03, 0.089, 233, 79, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 39 
1579, 6hv3a, 0.5030, 4.02, 0.089, 233, 79, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) 
1580, 6hv3M, 0.5030, 3.73, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) 
1581, 6avoQ, 0.5030, 3.73, 0.013, 243, 76, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1582, 6avoJ, 0.5030, 3.70, 0.013, 243, 76, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1583, 5laja, 0.5030, 3.70, 0.013, 243, 76, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1584, 5l64M, 0.5030, 4.03, 0.076, 233, 79, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1585, 5l5za, 0.5030, 3.69, 0.013, 244, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1586, 5jhsa, 0.5030, 4.16, 0.086, 233, 81, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1587, 5jhra, 0.5030, 4.05, 0.063, 222, 79, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1588, 4ya5T, 0.5030, 4.14, 0.024, 575, 83, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1589, 4rurM, 0.5030, 4.02, 0.089, 233, 79, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1590, 4qz0M, 0.5030, 4.03, 0.076, 233, 79, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1591, 4qxjF, 0.5030, 4.04, 0.076, 233, 79, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1592, 4qvya, 0.5030, 3.92, 0.091, 239, 77, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1593, 4qvyM, 0.5030, 3.92, 0.091, 239, 77, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1594, 4qv4a, 0.5030, 4.03, 0.076, 231, 79, YCP BETA5-M45T MUTANT
1595, 3sdiF, 0.5030, 4.15, 0.087, 233, 80, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1596, 3m4pD, 0.5030, 4.14, 0.087, 233, 80, ENTAMOEBA HISTOLYTICA ASPARAGINYL-TRNA SYNTHETASE (ASNRS) IN COMPLEX WITH ASPARAGINYL-ADENYLATE
1597, 6hwca, 0.5029, 4.03, 0.089, 233, 79, YEAST 20S PROTEASOME BETA2-G45A MUTANT 
1598, 6hwcM, 0.5029, 4.02, 0.076, 233, 79, YEAST 20S PROTEASOME BETA2-G45A MUTANT 
1599, 6htca, 0.5029, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH ONX 0914 
1600, 5mpaG, 0.5029, 4.14, 0.087, 233, 80, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1601, 5l64a, 0.5029, 4.02, 0.089, 233, 79, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1602, 5l5fT, 0.5029, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1603, 5l5fF, 0.5029, 4.17, 0.086, 233, 81, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1604, 5jhsM, 0.5029, 4.17, 0.086, 233, 81, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1605, 5jhrM, 0.5029, 4.03, 0.076, 233, 79, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1606, 5fgga, 0.5029, 3.73, 0.013, 242, 76, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1607, 5fggM, 0.5029, 3.90, 0.053, 435, 76, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1608, 5cz8M, 0.5029, 4.03, 0.089, 233, 79, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1609, 5cz4T, 0.5029, 4.03, 0.089, 233, 79, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1610, 5cz4F, 0.5029, 4.02, 0.114, 224, 79, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1611, 5bxna, 0.5029, 4.01, 0.038, 243, 78, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1612, 5bxnM, 0.5029, 4.15, 0.087, 233, 80, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1613, 4ya5F, 0.5029, 3.94, 0.013, 243, 78, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1614, 4ya0F, 0.5029, 3.94, 0.013, 243, 78, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1615, 4y9za, 0.5029, 4.03, 0.089, 233, 79, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1616, 4qxjT, 0.5029, 4.02, 0.076, 233, 79, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1617, 4qwkT, 0.5029, 4.05, 0.075, 233, 80, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1618, 4qw6M, 0.5029, 4.05, 0.075, 233, 80, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1619, 4qvnM, 0.5029, 4.03, 0.089, 233, 79, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1620, 4jsua, 0.5029, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1621, 4jsuM, 0.5029, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1622, 4fzgF, 0.5029, 4.07, 0.075, 233, 80, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1623, 3unea, 0.5029, 4.07, 0.075, 233, 80, MOUSE CONSTITUTIVE 20S PROTEASOME
1624, 3oevM, 0.5029, 3.70, 0.013, 243, 76, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1625, 3dy31, 0.5029, 3.70, 0.013, 243, 76, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1626, 3bdmZ, 0.5029, 4.16, 0.086, 233, 81, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1627, 6hwda, 0.5028, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH BORTEZOMIB 
1628, 6hvuL, 0.5028, 3.73, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 29 
1629, 5lajM, 0.5028, 4.03, 0.089, 233, 79, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1630, 5l62a, 0.5028, 4.06, 0.075, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1631, 5l62M, 0.5028, 4.05, 0.075, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1632, 5l5ya, 0.5028, 4.05, 0.075, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1633, 5l5yM, 0.5028, 3.70, 0.013, 244, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1634, 5l5sZ, 0.5028, 4.42, 0.122, 216, 82, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1635, 5l5da, 0.5028, 4.03, 0.089, 233, 79, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1636, 5l52L, 0.5028, 4.18, 0.074, 233, 81, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1637, 5cz7a, 0.5028, 4.05, 0.063, 222, 79, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1638, 5cz7M, 0.5028, 4.06, 0.075, 233, 80, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1639, 4ya0T, 0.5028, 4.01, 0.064, 222, 78, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1640, 4qvna, 0.5028, 4.03, 0.089, 228, 79, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1641, 4jsuT, 0.5028, 4.04, 0.089, 233, 79, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1642, 3uneM, 0.5028, 4.04, 0.089, 233, 79, MOUSE CONSTITUTIVE 20S PROTEASOME
1643, 3unbo, 0.5028, 4.16, 0.087, 233, 80, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1644, 3dy3M, 0.5028, 4.16, 0.087, 233, 80, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1645, 2gplT, 0.5028, 4.14, 0.063, 222, 79, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1646, 2gpl1, 0.5028, 4.17, 0.086, 233, 81, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1647, 1iru2, 0.5028, 4.14, 0.063, 222, 79, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1648, 6r70M, 0.5027, 4.03, 0.076, 233, 79, ENDOGENEOUS NATIVE HUMAN 20S PROTEASOME 
1649, 6hwdM, 0.5027, 4.03, 0.076, 233, 79, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH BORTEZOMIB 
1650, 6hw7a, 0.5027, 3.70, 0.013, 243, 76, YEAST 20S PROTEASOME IN COMPLEX WITH 29 
1651, 6hw7M, 0.5027, 4.06, 0.075, 233, 80, YEAST 20S PROTEASOME IN COMPLEX WITH 29 
1652, 5lf6a, 0.5027, 3.70, 0.013, 244, 76, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1653, 5lf4a, 0.5027, 4.32, 0.123, 216, 81, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1654, 5l60a, 0.5027, 4.40, 0.122, 216, 82, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1655, 4ya3T, 0.5027, 4.18, 0.074, 233, 81, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1656, 4ya3F, 0.5027, 4.19, 0.025, 244, 81, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1657, 4ya2a, 0.5027, 4.14, 0.100, 233, 80, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1658, 4ya2M, 0.5027, 4.40, 0.122, 217, 82, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1659, 4qw7M, 0.5027, 4.39, 0.122, 216, 82, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1660, 4jsuF, 0.5027, 4.06, 0.087, 233, 80, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1661, 4intT, 0.5027, 4.03, 0.089, 233, 79, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1662, 1iruN, 0.5027, 4.03, 0.089, 233, 79, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1663, 5leyM, 0.5026, 4.38, 0.122, 216, 82, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1664, 5l5oa, 0.5026, 4.38, 0.122, 216, 82, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1665, 5cz6M, 0.5026, 4.14, 0.087, 233, 80, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1666, 4y8ta, 0.5026, 3.71, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1667, 4y8tM, 0.5026, 3.71, 0.013, 243, 76, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1668, 4qvqM, 0.5026, 4.01, 0.114, 233, 79, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1669, 4q1sa, 0.5026, 4.01, 0.114, 233, 79, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1670, 4hnpF, 0.5026, 4.03, 0.089, 233, 79, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1671, 2akmB, 0.5026, 3.70, 0.013, 244, 76, FLUORIDE INHIBITION OF ENOLASE: CRYSTAL STRUCTURE OF THE INHIBITORY COMPLEX
1672, 1p48A, 0.5026, 3.58, 0.013, 244, 75, REVERSE PROTONATION IS THE KEY TO GENERAL ACID-BASE CATALYSIS IN ENOLASE
1673, 5nglA, 0.5025, 4.41, 0.122, 217, 82, THE ENDO-BETA16-GLUCANASE BT3312
1674, 5lf3M, 0.5025, 4.38, 0.122, 216, 82, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1675, 5cz6a, 0.5025, 4.04, 0.076, 233, 79, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1676, 4ya7a, 0.5025, 4.17, 0.086, 233, 81, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1677, 4ya7M, 0.5025, 4.02, 0.076, 233, 79, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1678, 4ya1L, 0.5025, 4.02, 0.076, 233, 79, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1679, 4qwsT, 0.5025, 4.03, 0.114, 233, 79, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1680, 4qwfa, 0.5025, 4.15, 0.086, 233, 81, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1681, 4qwfM, 0.5025, 3.70, 0.013, 244, 76, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1682, 4qvnZ, 0.5025, 4.10, 0.096, 432, 83, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1683, 4qvnL, 0.5025, 4.10, 0.085, 436, 82, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1684, 4qv3M, 0.5025, 3.84, 0.038, 450, 78, YCP BETA5-M45V MUTANT
1685, 4lqiT, 0.5025, 4.38, 0.122, 216, 82, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1686, 4j70M, 0.5025, 4.17, 0.086, 233, 81, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1687, 4intZ, 0.5025, 4.16, 0.086, 233, 81, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1688, 3un8L, 0.5025, 4.16, 0.086, 233, 81, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1689, 3mg0F, 0.5025, 3.92, 0.078, 222, 77, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1690, 2f161, 0.5025, 3.72, 0.013, 243, 76, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1691, 6hvvZ, 0.5024, 4.04, 0.089, 233, 79, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 39 
1692, 5vfrt, 0.5024, 4.04, 0.089, 233, 79, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1693, 5l68M, 0.5024, 4.02, 0.064, 222, 78, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1694, 5l61a, 0.5024, 4.02, 0.064, 222, 78, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1695, 5l61M, 0.5024, 4.07, 0.087, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1696, 5l5pM, 0.5024, 3.97, 0.025, 244, 79, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1697, 5bxlM, 0.5024, 4.17, 0.099, 233, 81, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1698, 4qwsF, 0.5024, 4.02, 0.064, 222, 78, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1699, 4qwkF, 0.5024, 4.01, 0.064, 222, 78, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1700, 4qvma, 0.5024, 3.68, 0.013, 244, 76, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1701, 3un8Z, 0.5024, 4.03, 0.089, 233, 79, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1702, 3un4T, 0.5024, 4.01, 0.064, 222, 78, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1703, 3un4F, 0.5024, 4.26, 0.123, 215, 81, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1704, 3mg01, 0.5024, 4.04, 0.089, 233, 79, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1705, 3k14A, 0.5024, 4.03, 0.076, 233, 79, CO-CRYSTAL STRUCTURE OF 2C-METHYL-D-ERYTHRITOL 24-CYCLODIPHOSPHATE SYNTHASE FROM BURKHOLDERIA PSEUDOMALLEI WITH FOL FRAGMENT 535 ETHYL 3-METHYL-56-DIHYDROIMIDAZO[21-B][13]THIAZOLE-2-CARBOXYLATE
1706, 2x3kB, 0.5024, 4.03, 0.076, 233, 79, CO-COMPLEX STRUCTURE OF ACHROMOBACTIN SYNTHETASE PROTEIN D ( ACSD) WITH AMP AND SULFATE FROM PECTOBACTERIUM CHRYSANTHEMI
1707, 2f16M, 0.5024, 4.04, 0.089, 233, 79, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1708, 6r70a, 0.5023, 4.06, 0.075, 229, 80, ENDOGENEOUS NATIVE HUMAN 20S PROTEASOME 
1709, 6hvaM, 0.5023, 3.73, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 13 
1710, 6htpL, 0.5023, 3.75, 0.013, 243, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 7 
1711, 5lf6M, 0.5023, 4.03, 0.114, 233, 79, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1712, 5lf3a, 0.5023, 4.01, 0.064, 222, 78, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1713, 5leya, 0.5023, 3.68, 0.013, 244, 76, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1714, 5l5hL, 0.5023, 3.68, 0.013, 244, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1715, 4qvmM, 0.5023, 4.03, 0.114, 233, 79, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1716, 4lqiF, 0.5023, 4.10, 0.114, 158, 79, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1717, 4inuL, 0.5023, 4.10, 0.024, 570, 82, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1718, 1g0u1, 0.5023, 4.03, 0.089, 233, 79, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1719, 6hwdZ, 0.5022, 4.39, 0.122, 216, 82, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH BORTEZOMIB 
1720, 6hw5T, 0.5022, 4.06, 0.075, 233, 80, YEAST 20S PROTEASOME IN COMPLEX WITH 18 
1721, 6hw0a, 0.5022, 4.04, 0.064, 222, 78, YEAST 20S PROTEASOME IN COMPLEX WITH 7 
1722, 5lezM, 0.5022, 4.39, 0.122, 216, 82, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1723, 5l5hZ, 0.5022, 4.39, 0.122, 216, 82, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1724, 5fg9a, 0.5022, 4.38, 0.122, 216, 82, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1725, 5cgga, 0.5022, 4.15, 0.063, 222, 79, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1726, 5cggM, 0.5022, 4.04, 0.089, 233, 79, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1727, 5bxla, 0.5022, 3.97, 0.025, 244, 79, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1728, 4qw4a, 0.5022, 4.02, 0.064, 222, 78, YCP IN COMPLEX WITH CARFILZOMIB
1729, 4qv8M, 0.5022, 4.26, 0.085, 233, 82, YCP BETA5-C52F MUTANT
1730, 4intL, 0.5022, 4.01, 0.064, 222, 78, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1731, 3mg4M, 0.5022, 3.72, 0.013, 243, 76, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1732, 3gpwM, 0.5022, 4.14, 0.087, 233, 80, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1733, 6hwdL, 0.5021, 4.39, 0.122, 216, 82, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH BORTEZOMIB 
1734, 6hw0L, 0.5021, 4.15, 0.063, 222, 79, YEAST 20S PROTEASOME IN COMPLEX WITH 7 
1735, 6hvtZ, 0.5021, 4.04, 0.089, 233, 79, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 20 
1736, 6hvtL, 0.5021, 4.07, 0.075, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 20 
1737, 6hv5Z, 0.5021, 4.07, 0.075, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 4 
1738, 6huuZ, 0.5021, 4.06, 0.075, 232, 80, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 29 
1739, 6hucL, 0.5021, 4.04, 0.089, 233, 79, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 18 
1740, 5mpcA, 0.5021, 4.07, 0.087, 233, 80, 
1741, 5l5xa, 0.5021, 4.02, 0.064, 222, 78, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1742, 5l5eZ, 0.5021, 4.04, 0.089, 233, 79, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1743, 5l5eL, 0.5021, 4.07, 0.075, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1744, 4y69a, 0.5021, 4.01, 0.064, 222, 78, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1745, 4qz2a, 0.5021, 4.02, 0.064, 222, 78, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1746, 4qv5a, 0.5021, 4.01, 0.064, 222, 78, YCP BETA5-M45I MUTANT
1747, 4qv5M, 0.5021, 4.01, 0.064, 222, 78, YCP BETA5-M45I MUTANT
1748, 3unbM, 0.5021, 4.03, 0.064, 222, 78, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1749, 6hw0Z, 0.5020, 4.03, 0.064, 222, 78, YEAST 20S PROTEASOME IN COMPLEX WITH 7 
1750, 6hvta, 0.5020, 4.03, 0.064, 222, 78, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 20 
1751, 6hvaa, 0.5020, 3.44, 0.079, 241, 76, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 13 
1752, 6huqZ, 0.5020, 4.04, 0.089, 233, 79, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 20 
1753, 6huqL, 0.5020, 3.96, 0.078, 222, 77, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 20 
1754, 6fvyO, 0.5020, 3.96, 0.078, 222, 77, struct.pdbx_descriptor              
1755, 5lttM, 0.5020, 4.14, 0.087, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1756, 5leza, 0.5020, 4.14, 0.087, 233, 80, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1757, 5l6cM, 0.5020, 4.07, 0.075, 233, 80, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1758, 5l65a, 0.5020, 4.07, 0.075, 233, 80, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1759, 5l65M, 0.5020, 4.40, 0.122, 216, 82, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1760, 5l5ha, 0.5020, 4.03, 0.064, 222, 78, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1761, 4r17T, 0.5020, 4.06, 0.075, 233, 80, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1762, 4r17F, 0.5020, 4.06, 0.075, 233, 80, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1763, 4r00a, 0.5020, 4.03, 0.064, 222, 78, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1764, 4qzzM, 0.5020, 4.03, 0.064, 222, 78, YCP IN COMPLEX WITH OMURALIDE
1765, 4qv7Z, 0.5020, 3.47, 0.079, 244, 76, YCP BETA5-A50V MUTANT
1766, 4qlva, 0.5020, 4.18, 0.086, 233, 81, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1767, 4qlvM, 0.5020, 4.39, 0.122, 216, 82, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1768, 4inuT, 0.5020, 4.04, 0.089, 233, 79, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1769, 4hrda, 0.5020, 4.04, 0.089, 233, 79, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1770, 4hrcF, 0.5020, 4.04, 0.089, 233, 79, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1771, 3unfa, 0.5020, 4.17, 0.086, 233, 81, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1772, 3unfM, 0.5020, 4.18, 0.037, 243, 81, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1773, 3mg4F, 0.5020, 4.18, 0.037, 243, 81, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1774, 3d291, 0.5020, 4.19, 0.086, 233, 81, PROTEASOME INHIBITION BY FELLUTAMIDE B
1775, 6hwea, 0.5019, 4.07, 0.087, 233, 80, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH CARFILZOMIB 
1776, 6hw5F, 0.5019, 4.15, 0.063, 222, 79, YEAST 20S PROTEASOME IN COMPLEX WITH 18 
1777, 6huuL, 0.5019, 4.03, 0.076, 233, 79, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 29 
1778, 6hucZ, 0.5019, 4.03, 0.076, 233, 79, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 18 
1779, 5lf7a, 0.5019, 3.58, 0.013, 244, 75, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1780, 5l63a, 0.5019, 4.03, 0.089, 233, 79, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1781, 5l63M, 0.5019, 3.72, 0.013, 244, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1782, 5cz9M, 0.5019, 4.33, 0.123, 216, 81, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1783, 5cgia, 0.5019, 4.33, 0.123, 216, 81, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1784, 5cgiM, 0.5019, 3.72, 0.013, 244, 76, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1785, 4r00M, 0.5019, 4.17, 0.099, 233, 81, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1786, 4qw3T, 0.5019, 4.04, 0.076, 233, 79, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1787, 4qlsZ, 0.5019, 3.73, 0.013, 243, 76, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1788, 4qlsL, 0.5019, 4.03, 0.064, 222, 78, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1789, 3wxrA, 0.5019, 4.03, 0.064, 222, 78, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1790, 6msgVA, 0.5018, 4.39, 0.122, 216, 82, struct.pdbx_descriptor               26S proteasome  
1791, 6msgHA, 0.5018, 4.07, 0.075, 233, 80, struct.pdbx_descriptor               26S proteasome  
1792, 6hweZ, 0.5018, 4.07, 0.075, 233, 80, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH CARFILZOMIB 
1793, 6hweM, 0.5018, 4.04, 0.089, 233, 79, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH CARFILZOMIB 
1794, 6hweL, 0.5018, 4.15, 0.087, 233, 80, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH CARFILZOMIB 
1795, 6hw8a, 0.5018, 4.15, 0.087, 233, 80, YEAST 20S PROTEASOME IN COMPLEX WITH 39 
1796, 6hw8M, 0.5018, 4.05, 0.089, 233, 79, YEAST 20S PROTEASOME IN COMPLEX WITH 39 
1797, 6hw4a, 0.5018, 3.59, 0.013, 243, 75, YEAST 20S PROTEASOME IN COMPLEX WITH 16 
1798, 6hw4M, 0.5018, 4.02, 0.064, 222, 78, YEAST 20S PROTEASOME IN COMPLEX WITH 16 
1799, 6hvya, 0.5018, 4.02, 0.064, 222, 78, YEAST 20S PROTEASOME IN COMPLEX WITH 5 (7- AND 6-MEMBERED RING) 
1800, 6htrM, 0.5018, 3.58, 0.039, 243, 77, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 13 
1801, 6htpZ, 0.5018, 4.42, 0.122, 215, 82, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 7 
1802, 6g8na, 0.5018, 4.42, 0.122, 215, 82, YEAST 20S PROTEASOME IN COMPLEX WITH CYSTARGOLIDE B DERIVATIVE 2 
1803, 6epdG, 0.5018, 4.02, 0.064, 222, 78, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
1804, 5l68a, 0.5018, 4.14, 0.087, 233, 80, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1805, 5l4gY, 0.5018, 4.02, 0.064, 222, 78, 
1806, 5gjqg, 0.5018, 4.04, 0.089, 233, 79, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1807, 5d0zL, 0.5018, 4.04, 0.089, 233, 79, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1808, 5cz9a, 0.5018, 4.04, 0.089, 233, 79, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1809, 4qz5a, 0.5018, 4.04, 0.089, 233, 79, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1810, 4qz5M, 0.5018, 4.14, 0.087, 233, 80, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1811, 4qz4a, 0.5018, 4.18, 0.086, 228, 81, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1812, 4qz4M, 0.5018, 4.03, 0.064, 222, 78, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1813, 4qwiZ, 0.5018, 4.04, 0.089, 232, 79, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1814, 4qwfZ, 0.5018, 4.11, 0.076, 245, 79, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1815, 4qw3F, 0.5018, 4.05, 0.089, 233, 79, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1816, 4lrzH, 0.5018, 4.48, 0.120, 217, 83, CRYSTAL STRUCTURE OF THE E.COLI DHAR(N)-DHAL COMPLEX
1817, 4jt0a, 0.5018, 4.30, 0.123, 216, 81, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1818, 4jt0M, 0.5018, 4.03, 0.064, 222, 78, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1819, 4jsqZ, 0.5018, 4.04, 0.089, 233, 79, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1820, 4jsqL, 0.5018, 4.31, 0.084, 225, 83, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1821, 4hrca, 0.5018, 4.31, 0.084, 225, 83, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1822, 3mg4T, 0.5018, 4.06, 0.087, 225, 80, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1823, 1jd2L, 0.5018, 4.06, 0.087, 225, 80, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1824, 1fntU, 0.5018, 4.04, 0.064, 222, 78, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1825, 6htdZ, 0.5017, 4.02, 0.064, 222, 78, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 4 
1826, 6htdL, 0.5017, 3.59, 0.013, 243, 75, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 4 
1827, 5lf7M, 0.5017, 3.57, 0.052, 291, 77, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1828, 5l5uZ, 0.5017, 4.16, 0.087, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1829, 5dkiM, 0.5017, 4.16, 0.087, 233, 80, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1830, 5d0zZ, 0.5017, 4.01, 0.064, 222, 78, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1831, 5cz5L, 0.5017, 4.01, 0.064, 222, 78, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1832, 4y8na, 0.5017, 4.04, 0.089, 233, 79, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1833, 4y69M, 0.5017, 3.59, 0.013, 244, 75, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1834, 4r67p, 0.5017, 4.07, 0.063, 222, 79, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1835, 4r67b, 0.5017, 3.85, 0.013, 240, 77, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1836, 4r3oN, 0.5017, 4.03, 0.064, 222, 78, HUMAN CONSTITUTIVE 20S PROTEASOME
1837, 4qwra, 0.5017, 4.03, 0.064, 222, 78, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1838, 4qwrM, 0.5017, 4.39, 0.122, 216, 82, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1839, 4qwlZ, 0.5017, 4.02, 0.064, 222, 78, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1840, 4qwlL, 0.5017, 4.27, 0.098, 233, 82, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1841, 4qwiL, 0.5017, 4.03, 0.064, 222, 78, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1842, 4qwfL, 0.5017, 4.04, 0.064, 222, 78, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1843, 4qvpZ, 0.5017, 4.16, 0.087, 223, 80, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1844, 4qvpL, 0.5017, 4.14, 0.087, 233, 80, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1845, 4inra, 0.5017, 4.41, 0.122, 217, 82, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1846, 3nzwM, 0.5017, 4.41, 0.122, 217, 82, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1847, 3m4qB, 0.5017, 4.29, 0.123, 217, 81, ENTAMOEBA HISTOLYTICA ASPARAGINYL-TRNA SYNTHETASE (ASNRS)
1848, 1pdzA, 0.5017, 4.04, 0.076, 233, 79, X-RAY STRUCTURE AND CATALYTIC MECHANISM OF LOBSTER ENOLASE
1849, 6mseVA, 0.5016, 4.04, 0.076, 233, 79, struct.pdbx_descriptor               26S proteasome  
1850, 6mseHA, 0.5016, 4.02, 0.064, 222, 78, struct.pdbx_descriptor               26S proteasome  
1851, 6j2qG, 0.5016, 4.02, 0.064, 222, 78, struct.pdbx_descriptor              
1852, 6htcZ, 0.5016, 4.04, 0.064, 222, 78, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH ONX 0914 
1853, 6htcM, 0.5016, 4.02, 0.064, 222, 78, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH ONX 0914 
1854, 6htcL, 0.5016, 4.03, 0.064, 222, 78, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH ONX 0914 
1855, 5l5dM, 0.5016, 4.03, 0.064, 222, 78, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1856, 5gjrTA, 0.5016, 4.04, 0.089, 233, 79, 
1857, 5d0xa, 0.5016, 4.07, 0.075, 233, 80, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1858, 5d0xM, 0.5016, 4.06, 0.052, 437, 77, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1859, 5d0sM, 0.5016, 4.07, 0.120, 433, 83, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1860, 4r67N, 0.5016, 4.32, 0.123, 215, 81, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1861, 4r672, 0.5016, 4.32, 0.123, 215, 81, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1862, 4qw6a, 0.5016, 3.94, 0.128, 233, 78, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1863, 4qvva, 0.5016, 4.04, 0.064, 222, 78, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1864, 4qvvM, 0.5016, 4.18, 0.086, 224, 81, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1865, 4quxa, 0.5016, 4.04, 0.064, 222, 78, YCP BETA5-A49T-MUTANT
1866, 4quxM, 0.5016, 4.07, 0.087, 233, 80, YCP BETA5-A49T-MUTANT
1867, 4ltcZ, 0.5016, 4.28, 0.123, 217, 81, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1868, 3uneL, 0.5016, 4.15, 0.087, 233, 80, MOUSE CONSTITUTIVE 20S PROTEASOME
1869, 3un8a, 0.5016, 4.15, 0.087, 233, 80, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1870, 3sdiM, 0.5016, 4.07, 0.087, 233, 80, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1871, 3nzw1, 0.5016, 4.41, 0.122, 217, 82, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1872, 3mg7M, 0.5016, 4.41, 0.122, 217, 82, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1873, 3mg41, 0.5016, 4.07, 0.075, 233, 80, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1874, 3hyeT, 0.5016, 4.16, 0.087, 233, 80, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1875, 3gpjF, 0.5016, 4.15, 0.087, 233, 80, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1876, 6j2nM, 0.5015, 4.08, 0.087, 233, 80, struct.pdbx_descriptor              
1877, 6fvvU, 0.5015, 4.08, 0.087, 233, 80, struct.pdbx_descriptor              
1878, 5lf4M, 0.5015, 4.01, 0.064, 222, 78, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1879, 5lf1a, 0.5015, 4.28, 0.099, 213, 81, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1880, 5gjrFA, 0.5015, 4.07, 0.087, 233, 80, 
1881, 5fgiM, 0.5015, 4.03, 0.076, 233, 79, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1882, 5d0sa, 0.5015, 4.07, 0.075, 233, 80, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1883, 4ya9Z, 0.5015, 4.16, 0.086, 233, 81, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1884, 4qlqa, 0.5015, 4.06, 0.089, 233, 79, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1885, 4qlqM, 0.5015, 3.97, 0.025, 244, 79, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1886, 4inua, 0.5015, 3.97, 0.025, 244, 79, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1887, 4eu2N, 0.5015, 3.75, 0.053, 222, 75, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1888, 3uneo, 0.5015, 3.55, 0.013, 242, 75, MOUSE CONSTITUTIVE 20S PROTEASOME
1889, 3mg7L, 0.5015, 4.28, 0.123, 216, 81, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1890, 3mg61, 0.5015, 4.29, 0.123, 216, 81, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1891, 3gptT, 0.5015, 4.41, 0.110, 216, 82, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1892, 1fntG, 0.5015, 4.06, 0.076, 232, 79, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1893, 6qm8G, 0.5014, 4.07, 0.087, 233, 80, LEISHMANIA TARENTOLAE PROTEASOME 20S SUBUNIT APO STRUCTURE 
1894, 6hwfM, 0.5014, 4.02, 0.064, 222, 78, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH ONX 0914 
1895, 6hwba, 0.5014, 4.17, 0.086, 233, 81, YEAST 20S PROTEASOME IN COMPLEX WITH 44B 
1896, 5le5a, 0.5014, 4.17, 0.086, 233, 81, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1897, 5gjrY, 0.5014, 4.05, 0.089, 233, 79, 
1898, 5fgia, 0.5014, 4.17, 0.086, 233, 81, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1899, 5fgha, 0.5014, 4.32, 0.123, 216, 81, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1900, 5fghM, 0.5014, 4.02, 0.064, 222, 78, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1901, 5dkja, 0.5014, 4.03, 0.114, 233, 79, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1902, 5dkjM, 0.5014, 3.97, 0.025, 244, 79, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1903, 5dkia, 0.5014, 3.85, 0.013, 240, 77, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1904, 5cz8a, 0.5014, 4.11, 0.089, 228, 79, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1905, 4y8ia, 0.5014, 4.17, 0.086, 233, 81, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1906, 4r3o2, 0.5014, 4.04, 0.089, 233, 79, HUMAN CONSTITUTIVE 20S PROTEASOME
1907, 4qzwa, 0.5014, 4.39, 0.122, 216, 82, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1908, 4qw0a, 0.5014, 3.94, 0.051, 243, 78, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1909, 4qw0M, 0.5014, 4.06, 0.076, 232, 79, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1910, 4qvpa, 0.5014, 4.06, 0.089, 233, 79, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1911, 4qvpM, 0.5014, 4.06, 0.089, 233, 79, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1912, 4inuF, 0.5014, 4.19, 0.086, 233, 81, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1913, 4hrcL, 0.5014, 4.18, 0.086, 233, 81, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1914, 4cr47, 0.5014, 4.05, 0.089, 233, 79, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
1915, 2fknA, 0.5014, 4.07, 0.075, 233, 80, CRYSTAL STRUCTURE OF UROCANASE FROM BACILLUS SUBTILIS
1916, 6j2qF, 0.5013, 4.15, 0.087, 233, 80, struct.pdbx_descriptor              
1917, 6hwfa, 0.5013, 4.29, 0.123, 217, 81, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH ONX 0914 
1918, 6hwaM, 0.5013, 4.04, 0.089, 233, 79, YEAST 20S PROTEASOME IN COMPLEX WITH 43 
1919, 5lf1M, 0.5013, 4.15, 0.087, 233, 80, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1920, 5l5wa, 0.5013, 4.15, 0.087, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1921, 5l5wM, 0.5013, 4.07, 0.087, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1922, 5l5aa, 0.5013, 4.07, 0.087, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1923, 5l5aM, 0.5013, 3.70, 0.013, 244, 76, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1924, 5gjqX, 0.5013, 4.04, 0.064, 222, 78, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1925, 5dkjL, 0.5013, 4.28, 0.073, 233, 82, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1926, 5d0va, 0.5013, 4.32, 0.033, 544, 90, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1927, 4y8ua, 0.5013, 3.87, 0.079, 222, 76, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1928, 4y8uM, 0.5013, 4.17, 0.086, 233, 81, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1929, 4qzwM, 0.5013, 4.05, 0.089, 233, 79, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1930, 4qw7Z, 0.5013, 4.29, 0.123, 216, 81, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1931, 4qw5a, 0.5013, 4.07, 0.075, 233, 80, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1932, 4qw5M, 0.5013, 4.07, 0.075, 233, 80, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1933, 4qw4Z, 0.5013, 4.07, 0.087, 233, 80, YCP IN COMPLEX WITH CARFILZOMIB
1934, 4qw4L, 0.5013, 4.07, 0.087, 233, 80, YCP IN COMPLEX WITH CARFILZOMIB
1935, 4no9a, 0.5013, 3.71, 0.053, 243, 76, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1936, 4hrdZ, 0.5013, 4.03, 0.064, 222, 78, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1937, 3gptF, 0.5013, 4.07, 0.075, 233, 80, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1938, 3ffeA, 0.5013, 4.05, 0.089, 233, 79, STRUCTURE OF ACHROMOBACTIN SYNTHETASE PROTEIN D (ACSD)
1939, 2fakL, 0.5013, 4.05, 0.089, 233, 79, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1940, 6j2nG, 0.5012, 4.04, 0.089, 233, 79, struct.pdbx_descriptor              
1941, 6hwaa, 0.5012, 4.02, 0.064, 222, 78, YEAST 20S PROTEASOME IN COMPLEX WITH 43 
1942, 6hedd, 0.5012, 4.07, 0.075, 233, 80, PAN-PROTEASOME IN STATE 5 
1943, 5fg9M, 0.5012, 4.07, 0.075, 233, 80, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1944, 5dkjZ, 0.5012, 4.03, 0.064, 222, 78, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1945, 5d0vM, 0.5012, 4.03, 0.064, 222, 78, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1946, 5cgfT, 0.5012, 4.03, 0.089, 233, 79, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1947, 5cgfF, 0.5012, 4.07, 0.063, 222, 79, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1948, 4y8hZ, 0.5012, 3.97, 0.025, 244, 79, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1949, 4y8hL, 0.5012, 4.08, 0.049, 574, 82, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1950, 4qz7a, 0.5012, 4.32, 0.146, 222, 82, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1951, 4qz7M, 0.5012, 4.14, 0.111, 229, 81, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1952, 4qz6Z, 0.5012, 4.05, 0.089, 233, 79, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1953, 4no6a, 0.5012, 3.90, 0.077, 237, 78, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1954, 4ltca, 0.5012, 4.08, 0.087, 233, 80, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1955, 4inuM, 0.5012, 4.03, 0.064, 222, 78, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1956, 4fzgT, 0.5012, 4.07, 0.075, 233, 80, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1957, 3oeuM, 0.5012, 3.98, 0.025, 243, 79, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1958, 3nzxG, 0.5012, 3.98, 0.025, 243, 79, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1959, 3mg0L, 0.5012, 4.02, 0.064, 222, 78, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1960, 6qm7G, 0.5011, 4.02, 0.064, 222, 78, LEISHMANIA TARENTOLAE PROTEASOME 20S SUBUNIT COMPLEXED WITH GSK3494245 
1961, 6hvwL, 0.5011, 4.05, 0.089, 233, 79, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 43 
1962, 5t0jM, 0.5011, 4.05, 0.089, 232, 79, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1963, 5d0wT, 0.5011, 4.02, 0.064, 222, 78, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1964, 5d0sL, 0.5011, 4.03, 0.089, 233, 79, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1965, 4y7ya, 0.5011, 4.17, 0.074, 233, 81, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1966, 4y7yM, 0.5011, 4.05, 0.076, 233, 79, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1967, 4xlgA, 0.5011, 3.84, 0.013, 244, 77, C. GLABRATA SLX1 IN COMPLEX WITH SLX4CCD.
1968, 4qz6L, 0.5011, 4.08, 0.075, 233, 80, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1969, 4no6M, 0.5011, 3.59, 0.039, 243, 77, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1970, 4ltcL, 0.5011, 4.03, 0.064, 222, 78, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1971, 3unha, 0.5011, 3.85, 0.064, 228, 78, MOUSE 20S IMMUNOPROTEASOME
1972, 3unhM, 0.5011, 4.02, 0.064, 222, 78, MOUSE 20S IMMUNOPROTEASOME
1973, 3sdiL, 0.5011, 3.93, 0.078, 240, 77, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1974, 3nzxU, 0.5011, 3.97, 0.025, 243, 79, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1975, 3nzwU, 0.5011, 4.02, 0.064, 222, 78, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1976, 3nzwT, 0.5011, 4.03, 0.114, 233, 79, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1977, 3nzwF, 0.5011, 4.03, 0.114, 233, 79, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1978, 3gptM, 0.5011, 4.11, 0.074, 260, 81, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1979, 3f0eA, 0.5011, 4.02, 0.064, 222, 78, CRYSTAL STRUCTURE OF 2C-METHYL-D-ERYTHRITOL 24-CYCLODIPHOSPHATE SYNTHASE FROM BURKHOLDERIA PSEUDOMALLEI
1980, 5t0cLB, 0.5010, 4.03, 0.089, 233, 79, 
1981, 5t0cFA, 0.5010, 4.02, 0.064, 222, 78, 
1982, 5m2bM, 0.5010, 4.33, 0.123, 216, 81, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1983, 5l68L, 0.5010, 4.33, 0.123, 216, 81, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1984, 5l5qM, 0.5010, 4.02, 0.064, 222, 78, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1985, 5d0wF, 0.5010, 3.59, 0.039, 243, 77, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1986, 5cz5M, 0.5010, 3.60, 0.039, 243, 77, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1987, 4ya9a, 0.5010, 3.98, 0.025, 244, 79, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1988, 4y8pM, 0.5010, 3.98, 0.025, 244, 79, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1989, 4y8ja, 0.5010, 4.07, 0.075, 233, 80, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1990, 4qz2L, 0.5010, 4.36, 0.122, 158, 82, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1991, 4jsuZ, 0.5010, 4.30, 0.111, 215, 81, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1992, 4jsuL, 0.5010, 4.30, 0.111, 215, 81, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1993, 3tddT, 0.5010, 4.04, 0.089, 233, 79, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1994, 3tddF, 0.5010, 4.15, 0.063, 222, 79, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1995, 3sdk1, 0.5010, 4.04, 0.089, 233, 79, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1996, 3ieqA, 0.5010, 3.97, 0.025, 243, 79, CRYSTAL STRUCTURE OF 2C-METHYL-D-ERYTHRITOL 24-CYCLODIPHOSPHATE SYNTHASE FROM BURKHOLDERIA PSEUDOMALLEI WITH CYTIDINE
1997, 3hyeU, 0.5010, 4.06, 0.089, 233, 79, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1998, 3d29F, 0.5010, 4.06, 0.075, 233, 80, PROTEASOME INHIBITION BY FELLUTAMIDE B
1999, 6msbVA, 0.5009, 4.07, 0.075, 224, 80, struct.pdbx_descriptor               26S proteasome  
2000, 6msbHA, 0.5009, 4.18, 0.086, 233, 81, struct.pdbx_descriptor               26S proteasome  
2001, 6j2xG, 0.5009, 4.01, 0.064, 222, 78, struct.pdbx_descriptor              
2002, 6j2qO, 0.5009, 4.06, 0.063, 222, 79, struct.pdbx_descriptor              
2003, 6g8nM, 0.5009, 4.06, 0.063, 222, 79, YEAST 20S PROTEASOME IN COMPLEX WITH CYSTARGOLIDE B DERIVATIVE 2 
2004, 5wvkO, 0.5009, 3.98, 0.025, 244, 79, 
2005, 5lf0M, 0.5009, 3.97, 0.025, 244, 79, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2006, 5le5M, 0.5009, 4.13, 0.087, 233, 80, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2007, 5l68Z, 0.5009, 4.24, 0.123, 158, 81, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2008, 5l5qa, 0.5009, 3.59, 0.039, 243, 77, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2009, 5ey1B, 0.5009, 3.99, 0.025, 244, 79, CRYSTAL STRUCTURE OF CODY FROM STAPHYLOCOCCUS AUREUS WITH GTP AND ILE
2010, 5cz5a, 0.5009, 4.43, 0.122, 215, 82, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2011, 4ya3a, 0.5009, 4.43, 0.122, 215, 82, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2012, 4y9zZ, 0.5009, 4.09, 0.101, 233, 79, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2013, 4y9zL, 0.5009, 3.48, 0.105, 243, 76, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2014, 4y8pa, 0.5009, 4.08, 0.075, 229, 80, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2015, 4no1a, 0.5009, 3.41, 0.080, 243, 75, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2016, 4nnnL, 0.5009, 4.30, 0.123, 216, 81, YCP IN COMPLEX WITH MG132
2017, 4j70a, 0.5009, 4.29, 0.123, 216, 81, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2018, 4hrdL, 0.5009, 4.15, 0.063, 222, 79, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2019, 3nzwG, 0.5009, 4.04, 0.089, 233, 79, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2020, 3mg71, 0.5009, 3.77, 0.026, 168, 78, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2021, 3mg0Z, 0.5009, 4.06, 0.089, 233, 79, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2022, 3gpw1, 0.5009, 4.25, 0.099, 233, 81, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2023, 3gpt1, 0.5009, 4.02, 0.064, 222, 78, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2024, 2fakG, 0.5009, 4.02, 0.064, 222, 78, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2025, 2f16G, 0.5009, 4.07, 0.075, 224, 80, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2026, 6hvyM, 0.5008, 4.03, 0.089, 233, 79, YEAST 20S PROTEASOME IN COMPLEX WITH 5 (7- AND 6-MEMBERED RING) 
2027, 5vfos, 0.5008, 4.02, 0.064, 222, 78, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2028, 5ltta, 0.5008, 4.08, 0.075, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2029, 5lf0a, 0.5008, 4.03, 0.064, 222, 78, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2030, 5l67M, 0.5008, 3.60, 0.039, 243, 77, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2031, 5jhsZ, 0.5008, 4.08, 0.075, 233, 80, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2032, 4y8pZ, 0.5008, 4.03, 0.064, 222, 78, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2033, 4y8pL, 0.5008, 4.18, 0.099, 233, 81, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2034, 4y8ma, 0.5008, 4.08, 0.087, 233, 80, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2035, 4y8mM, 0.5008, 3.60, 0.039, 243, 77, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2036, 4y84Z, 0.5008, 3.60, 0.039, 243, 77, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2037, 4y84L, 0.5008, 4.05, 0.089, 233, 79, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2038, 4qz3a, 0.5008, 3.83, 0.104, 213, 77, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2039, 4qz3Z, 0.5008, 4.08, 0.087, 233, 80, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2040, 4qxjM, 0.5008, 4.30, 0.123, 216, 81, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2041, 4qv6Z, 0.5008, 4.08, 0.087, 233, 80, YCP BETA5-A49V MUTANT
2042, 4qv6L, 0.5008, 4.03, 0.064, 222, 78, YCP BETA5-A49V MUTANT
2043, 4qlsa, 0.5008, 4.02, 0.064, 222, 78, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2044, 4qlsM, 0.5008, 4.02, 0.064, 222, 78, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2045, 4lrzF, 0.5008, 4.08, 0.075, 222, 80, CRYSTAL STRUCTURE OF THE E.COLI DHAR(N)-DHAL COMPLEX
2046, 3mg8M, 0.5008, 4.08, 0.075, 222, 80, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2047, 3mg7Z, 0.5008, 4.03, 0.064, 222, 78, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2048, 3gptU, 0.5008, 4.03, 0.064, 222, 78, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2049, 2f16U, 0.5008, 4.08, 0.087, 233, 80, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2050, 1g65L, 0.5008, 4.02, 0.064, 222, 78, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2051, 6fvxU, 0.5007, 4.05, 0.089, 228, 79, struct.pdbx_descriptor              
2052, 5l67a, 0.5007, 4.03, 0.064, 222, 78, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2053, 5l5xM, 0.5007, 4.03, 0.064, 222, 78, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2054, 5gjqu, 0.5007, 4.07, 0.075, 233, 80, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2055, 5fgeM, 0.5007, 4.07, 0.075, 233, 80, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2056, 4ya5a, 0.5007, 3.57, 0.052, 294, 77, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2057, 4ya5M, 0.5007, 4.22, 0.073, 233, 82, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2058, 4y8la, 0.5007, 4.07, 0.063, 222, 79, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2059, 4y8lM, 0.5007, 3.59, 0.039, 243, 77, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2060, 4y8ha, 0.5007, 3.60, 0.039, 243, 77, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2061, 4y8hM, 0.5007, 4.06, 0.063, 222, 79, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2062, 4y84M, 0.5007, 3.86, 0.013, 244, 77, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2063, 4y77Z, 0.5007, 4.08, 0.087, 233, 80, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2064, 4y77L, 0.5007, 4.08, 0.087, 233, 80, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2065, 4qz3L, 0.5007, 4.42, 0.122, 217, 82, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2066, 4qxja, 0.5007, 4.05, 0.089, 233, 79, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2067, 4qw7a, 0.5007, 4.15, 0.087, 233, 80, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2068, 2w04B, 0.5007, 4.15, 0.087, 233, 80, CO-COMPLEX STRUCTURE OF ACHROMOBACTIN SYNTHETASE PROTEIN D ( ACSD) WITH CITRATE IN ATP BINDING SITE FROM PECTOBACTERIUM CHRYSANTHEMI
2069, 6mskUA, 0.5006, 4.18, 0.086, 233, 81, struct.pdbx_descriptor               26S proteasome  
2070, 6mskGA, 0.5006, 4.18, 0.086, 230, 81, struct.pdbx_descriptor               26S proteasome  
2071, 5fgea, 0.5006, 4.07, 0.087, 233, 80, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2072, 4ya2L, 0.5006, 4.07, 0.087, 233, 80, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2073, 4y8qZ, 0.5006, 4.03, 0.076, 233, 79, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2074, 4y8qL, 0.5006, 4.03, 0.064, 222, 78, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2075, 4r00F, 0.5006, 4.03, 0.064, 222, 78, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2076, 4qzxM, 0.5006, 4.02, 0.064, 222, 78, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2077, 4qwiM, 0.5006, 4.05, 0.089, 226, 79, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2078, 4no9Z, 0.5006, 4.08, 0.075, 233, 80, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2079, 4no9L, 0.5006, 4.10, 0.024, 575, 82, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2080, 4hnpL, 0.5006, 4.33, 0.123, 215, 81, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2081, 3gptG, 0.5006, 4.33, 0.123, 215, 81, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2082, 2fakU, 0.5006, 4.05, 0.089, 233, 79, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2083, 2f16Z, 0.5006, 4.02, 0.064, 222, 78, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2084, 6j2xN, 0.5005, 4.04, 0.064, 222, 78, struct.pdbx_descriptor              
2085, 6hvrT, 0.5005, 4.04, 0.064, 222, 78, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 16 
2086, 6hvrF, 0.5005, 4.20, 0.037, 243, 81, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 16 
2087, 5lexa, 0.5005, 4.06, 0.089, 231, 79, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2088, 5l5fa, 0.5005, 4.05, 0.089, 233, 79, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2089, 5l5fM, 0.5005, 4.03, 0.064, 222, 78, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2090, 5jhsL, 0.5005, 4.03, 0.064, 222, 78, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2091, 5fgiZ, 0.5005, 4.04, 0.064, 222, 78, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2092, 5fgiL, 0.5005, 3.59, 0.039, 243, 77, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2093, 5fgfa, 0.5005, 3.60, 0.039, 243, 77, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2094, 5cgiZ, 0.5005, 4.31, 0.146, 222, 82, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2095, 5cghZ, 0.5005, 4.03, 0.103, 233, 78, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2096, 5cghL, 0.5005, 4.17, 0.025, 243, 81, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2097, 4y84a, 0.5005, 4.17, 0.025, 243, 81, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2098, 4qz1Z, 0.5005, 4.30, 0.123, 216, 81, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2099, 4qwia, 0.5005, 4.08, 0.087, 233, 80, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2100, 4qluX, 0.5005, 4.08, 0.087, 233, 80, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2101, 4qluJ, 0.5005, 4.03, 0.064, 222, 78, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2102, 3oeu1, 0.5005, 4.04, 0.064, 222, 78, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2103, 3mg0M, 0.5005, 4.04, 0.064, 222, 78, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2104, 5lexM, 0.5004, 4.08, 0.075, 233, 80, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2105, 5l66a, 0.5004, 4.01, 0.064, 222, 78, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2106, 5l66M, 0.5004, 4.04, 0.064, 222, 78, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2107, 5fgfM, 0.5004, 4.04, 0.064, 222, 78, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2108, 5cz4M, 0.5004, 4.04, 0.076, 233, 79, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2109, 4y8iZ, 0.5004, 4.02, 0.064, 222, 78, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2110, 4y8iL, 0.5004, 4.05, 0.089, 233, 79, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2111, 4y75a, 0.5004, 3.89, 0.120, 195, 75, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2112, 4y75M, 0.5004, 3.89, 0.120, 195, 75, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2113, 4qwja, 0.5004, 4.18, 0.086, 233, 81, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2114, 4qwjM, 0.5004, 4.18, 0.099, 233, 81, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2115, 4lqiU, 0.5004, 4.30, 0.123, 216, 81, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2116, 3sdkM, 0.5004, 4.08, 0.087, 233, 80, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2117, 3sdi1, 0.5004, 4.08, 0.087, 233, 80, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2118, 3gpwU, 0.5004, 4.08, 0.075, 233, 80, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2119, 2gplG, 0.5004, 4.16, 0.087, 229, 80, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2120, 1fntb, 0.5004, 4.02, 0.064, 222, 78, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2121, 6mshUA, 0.5003, 4.03, 0.064, 222, 78, struct.pdbx_descriptor               26S proteasome  
2122, 6mshGA, 0.5003, 4.07, 0.087, 224, 80, struct.pdbx_descriptor               26S proteasome  
2123, 6hwfL, 0.5003, 4.07, 0.087, 224, 80, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH ONX 0914 
2124, 6h39a, 0.5003, 4.06, 0.089, 228, 79, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC NON-COVALENT BINDING INHIBITOR RTS-V5 
2125, 6h39Z, 0.5003, 4.06, 0.089, 230, 79, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC NON-COVALENT BINDING INHIBITOR RTS-V5 
2126, 6h39M, 0.5003, 3.60, 0.039, 243, 77, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC NON-COVALENT BINDING INHIBITOR RTS-V5 
2127, 6fvxAA, 0.5003, 4.24, 0.073, 233, 82, struct.pdbx_descriptor              
2128, 5n0lA, 0.5003, 4.08, 0.075, 233, 80, THE STRUCTURE OF THE COFACTOR BINDING GAF DOMAIN OF THE NUTRIENT SENSOR CODY FROM CLOSTRIDIUM DIFFICILE
2129, 5l5eM, 0.5003, 3.60, 0.039, 243, 77, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2130, 5fgda, 0.5003, 3.60, 0.039, 243, 77, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2131, 5fgdM, 0.5003, 3.97, 0.104, 233, 77, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2132, 5d0ta, 0.5003, 4.34, 0.123, 215, 81, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2133, 5d0tM, 0.5003, 4.34, 0.123, 215, 81, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2134, 5cz8Z, 0.5003, 4.06, 0.063, 222, 79, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2135, 5cgiL, 0.5003, 4.06, 0.089, 233, 79, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2136, 4y8lL, 0.5003, 4.03, 0.064, 222, 78, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2137, 4y74M, 0.5003, 4.06, 0.089, 233, 79, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2138, 4rura, 0.5003, 4.00, 0.039, 222, 77, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2139, 4r18a, 0.5003, 3.71, 0.063, 156, 79, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2140, 4r18M, 0.5003, 4.09, 0.087, 233, 80, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2141, 4qwgT, 0.5003, 4.06, 0.089, 233, 79, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2142, 4qwgF, 0.5003, 4.06, 0.089, 233, 79, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2143, 4qvqa, 0.5003, 4.08, 0.087, 233, 80, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2144, 4qv7F, 0.5003, 4.08, 0.087, 231, 80, YCP BETA5-A50V MUTANT
2145, 4no6T, 0.5003, 4.02, 0.064, 222, 78, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2146, 4lqiG, 0.5003, 4.01, 0.064, 222, 78, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2147, 3dy4T, 0.5003, 4.03, 0.064, 222, 78, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2148, 1jd2M, 0.5003, 4.04, 0.076, 233, 79, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2149, 6epe6, 0.5002, 4.09, 0.087, 233, 80, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
2150, 5laia, 0.5002, 4.07, 0.075, 233, 80, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2151, 5laiM, 0.5002, 4.07, 0.075, 233, 80, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2152, 5l5ea, 0.5002, 3.61, 0.013, 243, 75, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2153, 5cz8L, 0.5002, 3.61, 0.013, 243, 75, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2154, 4qw4M, 0.5002, 4.09, 0.087, 233, 80, YCP IN COMPLEX WITH CARFILZOMIB
2155, 4qw3M, 0.5002, 3.99, 0.025, 243, 79, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2156, 3nzxF, 0.5002, 3.98, 0.025, 243, 79, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2157, 3mg8Z, 0.5002, 3.60, 0.039, 243, 77, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2158, 3ikeA, 0.5002, 3.98, 0.025, 244, 79, CRYSTAL STRUCTURE OF 2C-METHYL-D-ERYTHRITOL 24-CYCLODIPHOSPHATE SYNTHASE FROM BURKHOLDERIA PSEUDOMALLEI WITH CYTOSINE
2159, 3dy4F, 0.5002, 4.20, 0.086, 233, 81, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2160, 2w02A, 0.5002, 4.06, 0.050, 213, 80, CO-COMPLEX STRUCTURE OF ACHROMOBACTIN SYNTHETASE PROTEIN D ( ACSD) WITH ATP FROM PECTOBACTERIUM CHRYSANTHEMI
2161, 2gplU, 0.5002, 4.08, 0.087, 233, 80, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2162, 6hwfZ, 0.5001, 4.08, 0.087, 233, 80, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH ONX 0914 
2163, 6hvuZ, 0.5001, 4.09, 0.087, 233, 80, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 29 
2164, 6hvsL, 0.5001, 4.02, 0.064, 222, 78, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 18 
2165, 5l54a, 0.5001, 4.09, 0.087, 233, 80, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2166, 4r02M, 0.5001, 4.20, 0.086, 233, 81, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2167, 4qzxa, 0.5001, 3.99, 0.025, 244, 79, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2168, 4qz2M, 0.5001, 4.07, 0.063, 222, 79, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2169, 4qw3a, 0.5001, 4.26, 0.123, 158, 81, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2170, 4q1sT, 0.5001, 3.98, 0.025, 244, 79, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2171, 4cr4G, 0.5001, 4.05, 0.049, 575, 82, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2172, 2uzhC, 0.5001, 3.60, 0.039, 243, 77, MYCOBACTERIUM SMEGMATIS 2C-METHYL-D-ERYTHRITOL-24- CYCLODIPHOSPHATE SYNTHASE (ISPF)
2173, 1g0uM, 0.5001, 4.25, 0.074, 222, 81, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
